ID,Description,setSize,enrichmentScore,NES,pvalue,p.adjust,qvalues,ont,comparison
GO:0005912,adherens junction,413,0.394252536638781,1.77139793746357,0.00357142857142857,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0030055,cell-substrate junction,358,0.399986836766063,1.76950968953709,0.003584229390681,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0005924,cell-substrate adherens junction,354,0.401332843188263,1.77212491807958,0.00363636363636364,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0005911,cell-cell junction,288,0.345155877182373,1.51079189568388,0.00366300366300366,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0005925,focal adhesion,351,0.401720138140345,1.77345456907922,0.00367647058823529,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0031012,extracellular matrix,221,0.356131387258174,1.51615910809295,0.00367647058823529,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0070161,anchoring junction,426,0.388679228882743,1.7449300969823,0.00367647058823529,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0019898,extrinsic component of membrane,209,0.340335883465239,1.46214128903368,0.0037037037037037,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0030139,endocytic vesicle,218,0.332384743233461,1.42934377175693,0.0037037037037037,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0000790,nuclear chromatin,258,0.366805309429817,1.58034671405226,0.00371747211895911,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0000785,chromatin,388,0.318170876241903,1.43006682234064,0.00373134328358209,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0098552,side of membrane,347,0.37136730250126,1.66173380927433,0.00374531835205993,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0045121,membrane raft,245,0.34472207008362,1.48767461947571,0.0037593984962406,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0098857,membrane microdomain,246,0.343360801974969,1.48119000939151,0.0037593984962406,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0031252,cell leading edge,307,0.363098371802816,1.59342541144775,0.00380228136882129,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0098562,cytoplasmic side of membrane,144,0.448708141834598,1.83831654860936,0.00381679389312977,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0009898,cytoplasmic side of plasma membrane,132,0.475529633878874,1.91990008026206,0.00383141762452107,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0098797,plasma membrane protein complex,346,0.359861665718416,1.60512809964954,0.00384615384615385,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0005578,proteinaceous extracellular matrix,179,0.344058621522587,1.41710560197414,0.00386100386100386,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0019897,extrinsic component of plasma membrane,108,0.483326929867467,1.89344351540335,0.00386100386100386,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0000323,lytic vacuole,448,0.306487574518373,1.39413810127408,0.00392156862745098,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0005764,lysosome,448,0.306487574518373,1.39413810127408,0.00392156862745098,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0015629,actin cytoskeleton,370,0.326284000787733,1.47791482541592,0.00392156862745098,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0001726,ruffle,142,0.410383681350463,1.66941001459516,0.00393700787401575,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0043235,receptor complex,217,0.369869649088455,1.59112306869005,0.00396825396825397,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0044440,endosomal part,376,0.285813177807143,1.29697265675369,0.00408163265306122,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0000775,chromosome, centromeric region,169,-0.371091955229576,-1.55252377117259,0.00411522633744856,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0005840,ribosome,209,-0.346726710553422,-1.47683499921768,0.00416666666666667,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0000776,kinetochore,117,-0.404120481154472,-1.59190829972347,0.00418410041841004,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0005813,centrosome,447,-0.329457317639911,-1.51301986326951,0.00432900432900433,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0098687,chromosomal region,308,-0.326121316567834,-1.43114153082814,0.00434782608695652,0.0197755960729313,0.0107772938658005,CC,mono-sp-vs-hc
GO:0005759,mitochondrial matrix,369,-0.323206309354283,-1.45058861510965,0.00454545454545455,0.0200284090909091,0.0109150717703349,CC,mono-sp-vs-hc
GO:0030027,lamellipodium,149,0.355068894948981,1.43428957947041,0.00711743772241993,0.0298728813559322,0.0162801070472792,CC,mono-sp-vs-hc
GO:0044433,cytoplasmic vesicle part,446,0.299602665538961,1.37317431732239,0.00738007380073801,0.0298728813559322,0.0162801070472792,CC,mono-sp-vs-hc
GO:0098802,plasma membrane receptor complex,126,0.385981790221701,1.56148732154266,0.00766283524904215,0.0298728813559322,0.0162801070472792,CC,mono-sp-vs-hc
GO:0031256,leading edge membrane,108,0.424010200824978,1.6420449858253,0.00772200772200772,0.0298728813559322,0.0162801070472792,CC,mono-sp-vs-hc
GO:0031253,cell projection membrane,215,0.358054300143435,1.52490014217903,0.0078740157480315,0.0298728813559322,0.0162801070472792,CC,mono-sp-vs-hc
GO:0016604,nuclear body,328,-0.305928808058231,-1.36246328064034,0.00836820083682008,0.0298728813559322,0.0162801070472792,CC,mono-sp-vs-hc
GO:0000428,DNA-directed RNA polymerase complex,118,-0.392174663304908,-1.58036683559557,0.00847457627118644,0.0298728813559322,0.0162801070472792,CC,mono-sp-vs-hc
GO:0055029,nuclear DNA-directed RNA polymerase complex,118,-0.392174663304908,-1.58036683559557,0.00847457627118644,0.0298728813559322,0.0162801070472792,CC,mono-sp-vs-hc
GO:0044455,mitochondrial membrane part,161,0.330488415741787,1.36041669514934,0.011070110701107,0.0378625134264232,0.0206342924981627,CC,mono-sp-vs-hc
GO:0036477,somatodendritic compartment,470,0.270726118285313,1.24049623955773,0.0112781954887218,0.0378625134264232,0.0206342924981627,CC,mono-sp-vs-hc
GO:0031227,intrinsic component of endoplasmic reticulum membrane,117,0.359892923298844,1.43329614340083,0.0116279069767442,0.0381287182260681,0.0207793686487717,CC,mono-sp-vs-hc
GO:0005777,peroxisome,116,-0.398863029901965,-1.58456219227455,0.0123456790123457,0.0383152173913043,0.0208810068649886,CC,mono-sp-vs-hc
GO:0042579,microbody,116,-0.398863029901965,-1.58456219227455,0.0123456790123457,0.0383152173913043,0.0208810068649886,CC,mono-sp-vs-hc
GO:0005938,cell cortex,202,0.33381064915898,1.40283085718019,0.0125,0.0383152173913043,0.0208810068649886,CC,mono-sp-vs-hc
GO:0030880,RNA polymerase complex,119,-0.396999786900237,-1.59279565028217,0.0131578947368421,0.0394736842105263,0.0215123474980845,CC,mono-sp-vs-hc
GO:0044437,vacuolar part,344,0.295323890543311,1.31030421510536,0.0150943396226415,0.0443396226415094,0.0241641840450182,CC,mono-sp-vs-hc
GO:0010008,endosome membrane,352,0.28568008695639,1.28484267260742,0.0158730158730159,0.0456754130223518,0.024892162378736,CC,mono-sp-vs-hc
GO:0030176,integral component of endoplasmic reticulum membrane,113,0.351411332884967,1.39820494113895,0.0189393939393939,0.0534090909090909,0.0291068580542265,CC,mono-sp-vs-hc
GO:0061695,transferase complex, transferring phosphorus-containing groups,226,-0.30861856023526,-1.32460784266989,0.0193798449612403,0.0535795713634291,0.0291997664018688,CC,mono-sp-vs-hc
GO:0044450,microtubule organizing center part,129,-0.37017957829607,-1.45724136454236,0.02,0.0540727105384261,0.029468517128071,CC,mono-sp-vs-hc
GO:0043292,contractile fiber,157,0.342918173504966,1.3952379712277,0.0203252032520325,0.0540727105384261,0.029468517128071,CC,mono-sp-vs-hc
GO:0005681,spliceosomal complex,162,-0.326830172066065,-1.35944620000791,0.0208333333333333,0.0540851553509781,0.0294752992954192,CC,mono-sp-vs-hc
GO:0099568,cytoplasmic region,217,0.327204242432134,1.38266992095017,0.0210970464135021,0.0540851553509781,0.0294752992954192,CC,mono-sp-vs-hc
GO:0030016,myofibril,147,0.328655727296448,1.33368427450256,0.0272373540856031,0.068579766536965,0.037374564816711,CC,mono-sp-vs-hc
GO:0009897,external side of plasma membrane,185,0.312028287104746,1.30052996696434,0.0299625468164794,0.072839984502131,0.0396962961452449,CC,mono-sp-vs-hc
GO:0043209,myelin sheath,151,0.322614424383476,1.3118767278765,0.0299625468164794,0.072839984502131,0.0396962961452449,CC,mono-sp-vs-hc
GO:0032993,protein-DNA complex,138,0.349261887320808,1.39315418379187,0.0307692307692308,0.0735332464146023,0.0400741096548411,CC,mono-sp-vs-hc
GO:0044448,cell cortex part,101,0.356621495708826,1.37791746422566,0.033195020746888,0.0780082987551867,0.0425129213074179,CC,mono-sp-vs-hc
GO:0012506,vesicle membrane,403,0.272198518627739,1.23567236065709,0.0338345864661654,0.078121152425511,0.0425744242408533,CC,mono-sp-vs-hc
GO:0055037,recycling endosome,112,0.33806646103584,1.32167767230485,0.0343511450381679,0.078121152425511,0.0425744242408533,CC,mono-sp-vs-hc
GO:0030666,endocytic vesicle membrane,127,0.329684482563907,1.33432140038406,0.037037037037037,0.0828924162257496,0.045174665057706,CC,mono-sp-vs-hc
GO:0008324,cation transmembrane transporter activity,405,0.33646111389336,1.52352705532212,0.00352112676056338,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0046982,protein heterodimerization activity,345,0.330869771791674,1.48112668873271,0.003584229390681,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0003924,GTPase activity,191,0.400473003263604,1.70037293343768,0.00359712230215827,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0022890,inorganic cation transmembrane transporter activity,340,0.358048691089145,1.58937867427175,0.0036101083032491,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0015077,monovalent inorganic cation transmembrane transporter activity,219,0.40101353466277,1.70914909167765,0.00367647058823529,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0005126,cytokine receptor binding,183,0.383985338181135,1.57682193513471,0.00371747211895911,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0000976,transcription regulatory region sequence-specific DNA binding,486,0.288101907393037,1.33433368125068,0.00373134328358209,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0005509,calcium ion binding,416,0.384564746330947,1.73976811977032,0.00373134328358209,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0005125,cytokine activity,130,0.436856881338171,1.72920148559468,0.00377358490566038,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0017016,Ras GTPase binding,202,0.326718013340252,1.39099709954311,0.00377358490566038,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0000977,RNA polymerase II regulatory region sequence-specific DNA binding,427,0.300405635182881,1.37198585260419,0.00378787878787879,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0000987,core promoter proximal region sequence-specific DNA binding,270,0.317742856537948,1.39065516783449,0.00378787878787879,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0001159,core promoter proximal region DNA binding,270,0.317742856537948,1.39065516783449,0.00378787878787879,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0000981,RNA polymerase II transcription factor activity, sequence-specific DNA binding,410,0.338274843052697,1.52332842927572,0.00380228136882129,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0003779,actin binding,318,0.334684988418293,1.48109941834965,0.00381679389312977,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0019901,protein kinase binding,477,0.310956695759188,1.42913033491005,0.00381679389312977,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0000982,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,228,0.391499679813992,1.67498599483425,0.00383141762452107,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0001664,G-protein coupled receptor binding,158,0.410985689626982,1.71099538466461,0.00384615384615385,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0001012,RNA polymerase II regulatory region DNA binding,430,0.30389281386873,1.38427774547002,0.00386100386100386,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0051020,GTPase binding,238,0.32293053851632,1.3983613411978,0.00387596899224806,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0004857,enzyme inhibitor activity,251,0.323436018382951,1.39568443222877,0.00390625,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0004518,nuclease activity,173,-0.369401328074464,-1.5373156121629,0.00401606425702811,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0001077,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,155,0.392122189228374,1.62124629932485,0.00403225806451613,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0008168,methyltransferase activity,185,-0.372448376473183,-1.58379429500171,0.00408163265306122,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0001228,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,210,0.372459145362553,1.59262088637378,0.00413223140495868,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0016741,transferase activity, transferring one-carbon groups,191,-0.369749513904662,-1.56663173103781,0.004149377593361,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0016779,nucleotidyltransferase activity,120,-0.3971130228788,-1.56393496064963,0.00421940928270042,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0004386,helicase activity,141,-0.375293141836069,-1.54011850083241,0.00427350427350427,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0016874,ligase activity,348,-0.341354906476439,-1.52145659405107,0.00427350427350427,0.0187150014736222,0.00977244171436549,MF,mono-sp-vs-hc
GO:0001227,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,115,0.388365884605394,1.50493206911062,0.0072992700729927,0.0288276018613097,0.0150529541422504,MF,mono-sp-vs-hc
GO:0031267,small GTPase binding,218,0.311199691563314,1.33798503566482,0.00738007380073801,0.0288276018613097,0.0150529541422504,MF,mono-sp-vs-hc
GO:0000978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,261,0.313933009961926,1.37469677140623,0.00746268656716418,0.0288276018613097,0.0150529541422504,MF,mono-sp-vs-hc
GO:0003682,chromatin binding,385,0.278486978206829,1.27072720272598,0.00749063670411985,0.0288276018613097,0.0150529541422504,MF,mono-sp-vs-hc
GO:0004519,endonuclease activity,108,-0.369007815410717,-1.4614760301435,0.00803212851405622,0.0300023623907394,0.0156663806930508,MF,mono-sp-vs-hc
GO:0016887,ATPase activity,368,-0.277581804674104,-1.25320708522093,0.00869565217391304,0.0315527950310559,0.0164759725400458,MF,mono-sp-vs-hc
GO:0022804,active transmembrane transporter activity,241,0.321001269326828,1.37084399471232,0.0109090909090909,0.0384848484848485,0.0200956937799043,MF,mono-sp-vs-hc
GO:0050662,coenzyme binding,164,-0.324286709114009,-1.34838638072444,0.0153846153846154,0.0501629307791054,0.0261936563537807,MF,mono-sp-vs-hc
GO:0003714,transcription corepressor activity,179,0.335749780675259,1.38485695194149,0.0155038759689922,0.0501629307791054,0.0261936563537807,MF,mono-sp-vs-hc
GO:0048037,cofactor binding,220,-0.30333318461231,-1.29849001301695,0.0160642570281124,0.0501629307791054,0.0261936563537807,MF,mono-sp-vs-hc
GO:0000989,transcription factor activity, transcription factor binding,495,0.266108309239285,1.21764834960865,0.0161943319838057,0.0501629307791054,0.0261936563537807,MF,mono-sp-vs-hc
GO:0050839,cell adhesion molecule binding,138,0.327796950750761,1.3304000530188,0.0161943319838057,0.0501629307791054,0.0261936563537807,MF,mono-sp-vs-hc
GO:0042578,phosphoric ester hydrolase activity,288,0.284699856425408,1.25557774855212,0.0172413793103448,0.0521346469622332,0.0272232304900182,MF,mono-sp-vs-hc
GO:0042623,ATPase activity, coupled,278,-0.281906127040105,-1.23904568644901,0.0212765957446809,0.0627470355731225,0.0327647181194092,MF,mono-sp-vs-hc
GO:0008757,S-adenosylmethionine-dependent methyltransferase activity,116,-0.353627918283614,-1.42304687441718,0.0217391304347826,0.0627470355731225,0.0327647181194092,MF,mono-sp-vs-hc
GO:0000988,transcription factor activity, protein binding,497,0.26378934614823,1.20732199811091,0.0238095238095238,0.066027926322044,0.0344779059949339,MF,mono-sp-vs-hc
GO:0004721,phosphoprotein phosphatase activity,144,0.33490062414517,1.35480550389386,0.0252100840336134,0.066027926322044,0.0344779059949339,MF,mono-sp-vs-hc
GO:0046873,metal ion transmembrane transporter activity,253,0.299305293374148,1.29534469160345,0.0253623188405797,0.066027926322044,0.0344779059949339,MF,mono-sp-vs-hc
GO:0001047,core promoter binding,132,0.332426074138988,1.33384535104389,0.0262172284644195,0.066027926322044,0.0344779059949339,MF,mono-sp-vs-hc
GO:0019001,guanyl nucleotide binding,323,0.272080240407992,1.21671159822842,0.0262172284644195,0.066027926322044,0.0344779059949339,MF,mono-sp-vs-hc
GO:0005525,GTP binding,309,0.275340284101918,1.2300028230232,0.0264150943396226,0.066027926322044,0.0344779059949339,MF,mono-sp-vs-hc
GO:0032561,guanyl ribonucleotide binding,322,0.273371296291677,1.22076912937224,0.0265151515151515,0.066027926322044,0.0344779059949339,MF,mono-sp-vs-hc
GO:0003712,transcription cofactor activity,457,0.259373129979288,1.18607631651454,0.0274509803921569,0.0670437405731523,0.0350083353179328,MF,mono-sp-vs-hc
GO:0016791,phosphatase activity,211,0.294113840765123,1.2641039352367,0.028,0.0670943396226415,0.0350347567030785,MF,mono-sp-vs-hc
GO:0044389,ubiquitin-like protein ligase binding,239,0.296129621262748,1.27977792105894,0.0290909090909091,0.0684175084175084,0.035725677830941,MF,mono-sp-vs-hc
GO:0043492,ATPase activity, coupled to movement of substances,102,0.366694398445446,1.38827180155682,0.0305343511450382,0.0705065926439972,0.0368165382227255,MF,mono-sp-vs-hc
GO:0019902,phosphatase binding,149,0.326239205890297,1.31903067140757,0.0354330708661417,0.0803571428571428,0.0419602154993784,MF,mono-sp-vs-hc
GO:0019207,kinase regulator activity,149,0.332154465994724,1.34404676578184,0.0387596899224806,0.0852005903662955,0.0444893260926367,MF,mono-sp-vs-hc
GO:0019887,protein kinase regulator activity,134,0.333253750655492,1.33066555723825,0.0389105058365759,0.0852005903662955,0.0444893260926367,MF,mono-sp-vs-hc
GO:0019903,protein phosphatase binding,111,0.348852777919475,1.36717592926608,0.0423076923076923,0.0909505208333333,0.0474917763157895,MF,mono-sp-vs-hc
GO:0003729,mRNA binding,135,0.326535350789539,1.30484804326193,0.04296875,0.0909505208333333,0.0474917763157895,MF,mono-sp-vs-hc
GO:0005516,calmodulin binding,135,0.330291892346112,1.32790753988347,0.0448979591836735,0.0931706015739629,0.0486510393631137,MF,mono-sp-vs-hc
GO:0005539,glycosaminoglycan binding,116,0.331567007523629,1.31455651979885,0.0456273764258555,0.0931706015739629,0.0486510393631137,MF,mono-sp-vs-hc
GO:0008022,protein C-terminus binding,164,-0.305804160051408,-1.25939622329218,0.046218487394958,0.0931706015739629,0.0486510393631137,MF,mono-sp-vs-hc
GO:0031625,ubiquitin protein ligase binding,235,0.28888992173252,1.24107117373589,0.0481481481481481,0.0955439814814815,0.049890350877193,MF,mono-sp-vs-hc
GO:0023061,signal release,301,0.331021753213296,1.47250415585366,0.00336700336700337,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0032868,response to insulin,384,0.346869581372195,1.56730728044655,0.00341296928327645,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0043434,response to peptide hormone,491,0.356687597639375,1.65511111682384,0.00342465753424658,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1901653,cellular response to peptide,431,0.367730148256814,1.68120449055447,0.00343642611683849,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0008286,insulin receptor signaling pathway,291,0.340793428382848,1.49540430638267,0.00348432055749129,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0032869,cellular response to insulin stimulus,345,0.345894335708218,1.54564483947728,0.00350877192982456,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0048589,developmental growth,429,0.305785222298527,1.38336496220733,0.00350877192982456,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0071375,cellular response to peptide hormone stimulus,416,0.360526686250133,1.64127060303411,0.00352112676056338,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002009,morphogenesis of an epithelium,339,0.298060617900748,1.33230357158781,0.00353356890459364,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0051051,negative regulation of transport,366,0.324608361075404,1.46751051406709,0.00353356890459364,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0003013,circulatory system process,342,0.345484383431861,1.54868489300448,0.00354609929078014,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006163,purine nucleotide metabolic process,394,0.307005723665411,1.38865567978844,0.00354609929078014,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0042063,gliogenesis,184,0.331377873165709,1.4121662088192,0.00354609929078014,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0043410,positive regulation of MAPK cascade,478,0.329203536576245,1.51038204371901,0.00354609929078014,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0008543,fibroblast growth factor receptor signaling pathway,266,0.310331194111326,1.35837793658332,0.00355871886120996,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0010035,response to inorganic substance,409,0.301275765888502,1.36081027108057,0.00355871886120996,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0031668,cellular response to extracellular stimulus,159,0.395472727992883,1.62549537854196,0.00355871886120996,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0032388,positive regulation of intracellular transport,299,0.309241920117382,1.3665498237808,0.00355871886120996,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0009636,response to toxic substance,205,0.374490498648035,1.59350809067979,0.00357142857142857,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0015833,peptide transport,248,0.395711043500968,1.71710743674348,0.00357142857142857,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0038179,neurotrophin signaling pathway,347,0.355667228423433,1.60016409839331,0.00357142857142857,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0051090,regulation of sequence-specific DNA binding transcription factor activity,301,0.371973930571185,1.65450746730771,0.00357142857142857,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0008015,blood circulation,340,0.347173127231022,1.55481712446114,0.003584229390681,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0045664,regulation of neuron differentiation,389,0.346385488218765,1.5764951372965,0.003584229390681,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0000186,activation of MAPKK activity,197,0.375533544958758,1.58600294427111,0.00359712230215827,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002220,innate immune response activating cell surface receptor signaling pathway,121,0.392541426061239,1.55681201794299,0.00359712230215827,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002526,acute inflammatory response,104,0.429163282168821,1.64604016662516,0.00359712230215827,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006959,humoral immune response,121,0.443978358025277,1.74076206339568,0.00359712230215827,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0040008,regulation of growth,490,0.342748545642144,1.56102016992483,0.00359712230215827,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0055080,cation homeostasis,443,0.327150595201722,1.50612535010727,0.00359712230215827,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0072521,purine-containing compound metabolic process,432,0.283738739499187,1.29429264685373,0.00359712230215827,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1903827,regulation of cellular protein localization,474,0.293102215538367,1.35604217636658,0.00359712230215827,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0010817,regulation of hormone levels,326,0.329226421115826,1.46082033012927,0.0036101083032491,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0030003,cellular cation homeostasis,389,0.324400395579262,1.48334585402348,0.0036101083032491,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0031344,regulation of cell projection organization,395,0.335840882583988,1.53325508642542,0.0036101083032491,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0038095,Fc-epsilon receptor signaling pathway,264,0.361316939197139,1.58225976488208,0.0036101083032491,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0048011,neurotrophin TRK receptor signaling pathway,345,0.354639655185997,1.5924918988685,0.0036101083032491,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0050727,regulation of inflammatory response,218,0.35812605513569,1.51980735536399,0.0036101083032491,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0097193,intrinsic apoptotic signaling pathway,265,0.368972766699254,1.60056491216173,0.0036101083032491,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0007596,blood coagulation,457,0.422988985292846,1.94444451807351,0.0036231884057971,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0009259,ribonucleotide metabolic process,388,0.311854518630953,1.40842943740261,0.0036231884057971,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0042886,amide transport,265,0.376393753148944,1.64124557803393,0.0036231884057971,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0044344,cellular response to fibroblast growth factor stimulus,279,0.323916019198454,1.42470842411763,0.0036231884057971,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0046883,regulation of hormone secretion,191,0.388493237379491,1.63322471715517,0.0036231884057971,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0050801,ion homeostasis,494,0.325725742221624,1.50194635481492,0.0036231884057971,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0007599,hemostasis,462,0.421914993881105,1.93785799563441,0.00363636363636364,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0009914,hormone transport,228,0.371741857468132,1.59579476097498,0.00363636363636364,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0010959,regulation of metal ion transport,230,0.396199490766808,1.71518458614156,0.00363636363636364,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0010975,regulation of neuron projection development,291,0.340494144275434,1.50755355551959,0.00363636363636364,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0051091,positive regulation of sequence-specific DNA binding transcription factor activity,184,0.348393993900304,1.46806279606349,0.00363636363636364,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1903034,regulation of response to wounding,304,0.338286567613514,1.48890902750054,0.00363636363636364,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002790,peptide secretion,193,0.408928588132561,1.72651047802113,0.00364963503649635,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0031667,response to nutrient levels,394,0.307725531731638,1.38162534002519,0.00364963503649635,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0050767,regulation of neurogenesis,470,0.306519861416277,1.41239264957615,0.00364963503649635,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0050817,coagulation,460,0.418587477749481,1.92357530625327,0.00364963503649635,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002791,regulation of peptide secretion,161,0.431084746033283,1.77604084348811,0.00366300366300366,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0015672,monovalent inorganic cation transport,379,0.327539922307699,1.47337014963142,0.00366300366300366,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0071774,response to fibroblast growth factor,283,0.320375163893441,1.4076984114931,0.00366300366300366,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0098771,inorganic ion homeostasis,452,0.335924737984221,1.54567374098656,0.00366300366300366,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002768,immune response-regulating cell surface receptor signaling pathway,451,0.335836707719213,1.53442010447785,0.00367647058823529,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0003015,heart process,173,0.357928541561138,1.4957953383646,0.00367647058823529,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0007411,axon guidance,427,0.338447092290179,1.54458194773441,0.00367647058823529,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0009199,ribonucleoside triphosphate metabolic process,200,0.346128140521923,1.4594946923946,0.00367647058823529,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0016925,protein sumoylation,121,-0.432290692276052,-1.73245498963748,0.00367647058823529,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0019693,ribose phosphate metabolic process,400,0.308397687094366,1.39035674125941,0.00367647058823529,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0033157,regulation of intracellular protein transport,323,0.330268123265299,1.47537896638589,0.00367647058823529,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0043405,regulation of MAP kinase activity,394,0.332260689007691,1.50058196350459,0.00367647058823529,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0055065,metal ion homeostasis,406,0.332326768977163,1.51937944764804,0.00367647058823529,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0072593,reactive oxygen species metabolic process,200,0.393650327223312,1.65126942833594,0.00367647058823529,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0097305,response to alcohol,269,0.382817109286127,1.67261182601294,0.00367647058823529,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0097485,neuron projection guidance,427,0.338447092290179,1.54458194773441,0.00367647058823529,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006898,receptor-mediated endocytosis,213,0.349194057016811,1.47895252255001,0.003690036900369,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0009150,purine ribonucleotide metabolic process,374,0.316724257590154,1.42100985386464,0.003690036900369,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0009991,response to extracellular stimulus,416,0.317681619030901,1.43771802333146,0.003690036900369,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0030168,platelet activation,220,0.505999000145609,2.1524457153369,0.003690036900369,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0044057,regulation of system process,337,0.336190853170652,1.49737171468068,0.003690036900369,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0046879,hormone secretion,223,0.373243525151608,1.58880168253064,0.003690036900369,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002449,lymphocyte mediated immunity,189,0.359741252371849,1.52374557984368,0.0037037037037037,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0010001,glial cell differentiation,135,0.374303871843697,1.52556729350228,0.0037037037037037,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0034330,cell junction organization,206,0.338837718484756,1.44193393583086,0.0037037037037037,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0034765,regulation of ion transmembrane transport,267,0.332869701061474,1.46316230651908,0.0037037037037037,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0048511,rhythmic process,241,0.415717375959102,1.78362444843528,0.0037037037037037,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0090087,regulation of peptide transport,204,0.391310233034878,1.64390689934306,0.0037037037037037,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1904950,negative regulation of establishment of protein localization,182,0.40914174882088,1.73490700515513,0.0037037037037037,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0007009,plasma membrane organization,225,0.369936115038251,1.56213122368882,0.00371747211895911,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0007568,aging,232,0.369147301149036,1.58564301859331,0.00371747211895911,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0030072,peptide hormone secretion,188,0.392021779234809,1.64514059920235,0.00371747211895911,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0033002,muscle cell proliferation,116,0.377240081492595,1.49182987877964,0.00371747211895911,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0038093,Fc receptor signaling pathway,320,0.372916359753324,1.65423774434833,0.00371747211895911,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0060047,heart contraction,172,0.358020904825716,1.49345288270185,0.00371747211895911,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1900542,regulation of purine nucleotide metabolic process,127,0.380296245328644,1.50727072822217,0.00371747211895911,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1901654,response to ketone,138,0.455100461397815,1.84240119989562,0.00371747211895911,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0001501,skeletal system development,308,0.342651953009216,1.52460459086728,0.00373134328358209,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0009205,purine ribonucleoside triphosphate metabolic process,194,0.355640980968819,1.49481820547927,0.00373134328358209,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0036293,response to decreased oxygen levels,240,0.357321829196409,1.54426384603547,0.00373134328358209,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0048598,embryonic morphogenesis,397,0.328385140468444,1.49026909097324,0.00373134328358209,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0010720,positive regulation of cell development,344,0.34509208454256,1.54676358664291,0.00374531835205993,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0031346,positive regulation of cell projection organization,231,0.357809046627805,1.52840627268285,0.00374531835205993,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0036294,cellular response to decreased oxygen levels,116,0.423606952213379,1.68177236421177,0.00374531835205993,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0071902,positive regulation of protein serine/threonine kinase activity,248,0.368050960759332,1.58762992164345,0.00374531835205993,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0090276,regulation of peptide hormone secretion,158,0.41166130921212,1.67655505538815,0.00374531835205993,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0098662,inorganic cation transmembrane transport,444,0.357519462130782,1.63283044878032,0.00374531835205993,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1904062,regulation of cation transmembrane transport,154,0.386456859023473,1.58631605780516,0.00374531835205993,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:2000377,regulation of reactive oxygen species metabolic process,133,0.430577147410892,1.69915794769133,0.00374531835205993,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002521,leukocyte differentiation,395,0.328569958576651,1.4869226219223,0.0037593984962406,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006140,regulation of nucleotide metabolic process,133,0.381271759727924,1.52155320593533,0.0037593984962406,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006873,cellular ion homeostasis,398,0.333449217318779,1.51661676645757,0.0037593984962406,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0007015,actin filament organization,261,0.355931704768349,1.55199066341227,0.0037593984962406,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0007623,circadian rhythm,152,0.440480973886369,1.78520045654781,0.0037593984962406,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0010038,response to metal ion,262,0.324490617245425,1.40547238504345,0.0037593984962406,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0032147,activation of protein kinase activity,385,0.334965650154395,1.50482942454064,0.0037593984962406,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0070482,response to oxygen levels,253,0.359606851466489,1.5644716827006,0.0037593984962406,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0098660,inorganic ion transmembrane transport,485,0.351827253158248,1.62636891814455,0.0037593984962406,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1903649,regulation of cytoplasmic transport,388,0.323633080797979,1.4651735305196,0.0037593984962406,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006897,endocytosis,497,0.351805699798103,1.63361697913922,0.00377358490566038,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0019932,second-messenger-mediated signaling,177,0.388666353627354,1.59555041428564,0.00377358490566038,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0061448,connective tissue development,150,0.389972721500206,1.59574364757961,0.00377358490566038,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0071496,cellular response to external stimulus,220,0.385704023674915,1.6431514239387,0.00377358490566038,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0001568,blood vessel development,439,0.340548208434212,1.54273583384523,0.00378787878787879,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006112,energy reserve metabolic process,136,0.393110359039895,1.58904905216671,0.00378787878787879,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006364,rRNA processing,150,-0.528096990864053,-2.15553836048575,0.00378787878787879,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0016049,cell growth,368,0.330564620937757,1.46123812519014,0.00378787878787879,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0051224,negative regulation of protein transport,173,0.403335844512832,1.69501147703842,0.00378787878787879,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0051235,maintenance of location,240,0.379090617767338,1.65174497400184,0.00378787878787879,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0071559,response to transforming growth factor beta,207,0.332262488138323,1.41572931365655,0.00378787878787879,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0000723,telomere maintenance,122,-0.401386230030017,-1.62351131785593,0.00380228136882129,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0001944,vasculature development,459,0.3405996404511,1.55572076107842,0.00380228136882129,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0048514,blood vessel morphogenesis,368,0.358433454176173,1.60402105484841,0.00380228136882129,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0071453,cellular response to oxygen levels,123,0.406249740257073,1.62029977786485,0.00380228136882129,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:2001235,positive regulation of apoptotic signaling pathway,172,0.371555755547506,1.53375773407095,0.00380228136882129,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0001558,regulation of cell growth,292,0.340637392304097,1.47657012004918,0.00381679389312977,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006875,cellular metal ion homeostasis,359,0.32509072449539,1.46549453376159,0.00381679389312977,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0007179,transforming growth factor beta receptor signaling pathway,172,0.346581590691946,1.43642874270273,0.00381679389312977,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0009617,response to bacterium,400,0.390743967339835,1.77991880520073,0.00381679389312977,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0015980,energy derivation by oxidation of organic compounds,322,0.348141979343482,1.5437028002068,0.00381679389312977,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0032271,regulation of protein polymerization,151,0.385811097744779,1.59144666889292,0.00381679389312977,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0032845,negative regulation of homeostatic process,145,0.375197396573694,1.51726900998129,0.00381679389312977,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0043269,regulation of ion transport,386,0.332020500831404,1.50046975019739,0.00381679389312977,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0050865,regulation of cell activation,406,0.320202157473206,1.45574515886192,0.00381679389312977,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0098655,cation transmembrane transport,485,0.369334326052219,1.69803780510885,0.00381679389312977,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1903706,regulation of hemopoiesis,273,0.360826084701283,1.58897837740026,0.00381679389312977,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006403,RNA localization,184,-0.408351954588322,-1.71697075995244,0.00383141762452107,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0008016,regulation of heart contraction,149,0.365912876588668,1.48993704490918,0.00383141762452107,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0015931,nucleobase-containing compound transport,179,-0.371471742657754,-1.57247163286549,0.00383141762452107,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0022613,ribonucleoprotein complex biogenesis,361,-0.461421892403247,-2.0782556375603,0.00383141762452107,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0030029,actin filament-based process,498,0.338278625331002,1.55749838661036,0.00383141762452107,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0031589,cell-substrate adhesion,232,0.412553556607756,1.79558973304854,0.00383141762452107,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0042254,ribosome biogenesis,224,-0.529078525790702,-2.24739024120616,0.00383141762452107,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0048010,vascular endothelial growth factor receptor signaling pathway,254,0.408852999734188,1.7689888674597,0.00383141762452107,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0048762,mesenchymal cell differentiation,124,0.392690551563872,1.5664618527949,0.00383141762452107,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0050657,nucleic acid transport,151,-0.392904130200165,-1.62414382672024,0.00383141762452107,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0050658,RNA transport,151,-0.392904130200165,-1.62414382672024,0.00383141762452107,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0055082,cellular chemical homeostasis,497,0.336420375412912,1.5611345469825,0.00383141762452107,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0071456,cellular response to hypoxia,109,0.470290503849032,1.85264230981483,0.00383141762452107,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0097285,cell-type specific apoptotic process,353,0.305545787044188,1.3654054140625,0.00383141762452107,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0001667,ameboidal-type cell migration,240,0.319748522056068,1.39504223283164,0.00384615384615385,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006091,generation of precursor metabolites and energy,394,0.35966359990677,1.62517994844492,0.00384615384615385,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0030073,insulin secretion,160,0.425017605405144,1.73978161349522,0.00384615384615385,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0032200,telomere organization,134,-0.374500085585393,-1.52623689618289,0.00384615384615385,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0034762,regulation of transmembrane transport,279,0.32626390688814,1.43204932262496,0.00384615384615385,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0050796,regulation of insulin secretion,140,0.441562360017006,1.77971515401149,0.00384615384615385,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0051028,mRNA transport,126,-0.412444830870837,-1.66413326464687,0.00384615384615385,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0070509,calcium ion import,113,0.464167014205665,1.84611796213273,0.00384615384615385,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0070663,regulation of leukocyte proliferation,179,0.361182239603519,1.50927519182751,0.00384615384615385,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:2001234,negative regulation of apoptotic signaling pathway,167,0.4091015516122,1.72117615184179,0.00384615384615385,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0007265,Ras protein signal transduction,397,0.358717426414365,1.61399896613182,0.00386100386100386,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0008360,regulation of cell shape,112,0.467251634126309,1.85544671707045,0.00386100386100386,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0030855,epithelial cell differentiation,381,0.304610860125486,1.37050169100811,0.00386100386100386,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1902107,positive regulation of leukocyte differentiation,117,0.398364981399869,1.56266476892241,0.00386100386100386,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1903522,regulation of blood circulation,196,0.382907382587709,1.60058821646277,0.00386100386100386,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:2000021,regulation of ion homeostasis,141,0.382170996821925,1.52869836695666,0.00386100386100386,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0001101,response to acid chemical,243,0.357731340337735,1.54992036130904,0.00387596899224806,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0031960,response to corticosteroid,123,0.426291461317988,1.68961079397357,0.00387596899224806,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0090066,regulation of anatomical structure size,365,0.331983342948474,1.4828327847723,0.00387596899224806,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1902532,negative regulation of intracellular signal transduction,373,0.330675239631636,1.5144114858001,0.00387596899224806,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002683,negative regulation of immune system process,306,0.321048333312365,1.40049219081269,0.00389105058365759,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0007160,cell-matrix adhesion,151,0.415056238698133,1.69896628138503,0.00389105058365759,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0016072,rRNA metabolic process,154,-0.52125432181954,-2.12690119564857,0.00389105058365759,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0032535,regulation of cellular component size,280,0.33134631658861,1.44780023100279,0.00389105058365759,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0051236,establishment of RNA localization,154,-0.392783280988911,-1.62172677356671,0.00389105058365759,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0051384,response to glucocorticoid,118,0.445831115221792,1.7658042332823,0.00389105058365759,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0070371,ERK1 and ERK2 cascade,178,0.360592139946452,1.48594318864656,0.00389105058365759,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002250,adaptive immune response,299,0.324289447358546,1.42935808045617,0.00390625,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0022408,negative regulation of cell-cell adhesion,115,0.427736912297469,1.68991927287258,0.00390625,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:2001233,regulation of apoptotic signaling pathway,333,0.354306196849936,1.57546097313652,0.00390625,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:2001242,regulation of intrinsic apoptotic signaling pathway,133,0.438952310550401,1.75822520047673,0.00390625,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002443,leukocyte mediated immunity,251,0.323124711455387,1.40200738069424,0.00392156862745098,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002694,regulation of leukocyte activation,380,0.321624942183694,1.45207341844965,0.00392156862745098,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0070661,leukocyte proliferation,227,0.329608657484192,1.40889958105344,0.00392156862745098,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0072503,cellular divalent inorganic cation homeostasis,276,0.30810573414349,1.35444042681354,0.00392156862745098,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0032970,regulation of actin filament-based process,254,0.357297960548931,1.56086317883489,0.00393700787401575,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0046777,protein autophosphorylation,190,0.3513301776302,1.48225472491355,0.00393700787401575,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0050670,regulation of lymphocyte proliferation,173,0.365297313635731,1.52067236688395,0.00393700787401575,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0051258,protein polymerization,196,0.370134448889431,1.54362811773941,0.00393700787401575,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0071396,cellular response to lipid,417,0.338592487958915,1.55119761800733,0.00393700787401575,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0001503,ossification,268,0.356008466383588,1.56522545334273,0.00395256916996047,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002064,epithelial cell development,163,0.357808173577324,1.46648014290626,0.00395256916996047,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006816,calcium ion transport,266,0.363196721478006,1.60535748232017,0.00395256916996047,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0034142,toll-like receptor 4 signaling pathway,112,0.396028648786189,1.56507351847732,0.00395256916996047,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0045088,regulation of innate immune response,361,0.33438409424881,1.50892920943753,0.00395256916996047,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0070372,regulation of ERK1 and ERK2 cascade,168,0.361542763184532,1.48077572728802,0.00395256916996047,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0001818,negative regulation of cytokine production,198,0.36344589636874,1.52960925499173,0.00396825396825397,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0007584,response to nutrient,146,0.34727163426619,1.41171902650442,0.00396825396825397,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0010876,lipid localization,246,0.330616800138012,1.43388266184213,0.00396825396825397,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0032496,response to lipopolysaccharide,273,0.395556535696883,1.73288834863344,0.00396825396825397,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0042110,T cell activation,382,0.333921431716348,1.50595791688287,0.00396825396825397,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0051924,regulation of calcium ion transport,148,0.411877242693823,1.68982677385741,0.00396825396825397,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0060485,mesenchyme development,155,0.397734985454926,1.62580556593589,0.00396825396825397,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0070489,T cell aggregation,382,0.333921431716348,1.50595791688287,0.00396825396825397,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0071593,lymphocyte aggregation,383,0.332585021065141,1.49875754663353,0.00396825396825397,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0001666,response to hypoxia,232,0.372733774657612,1.59257572099558,0.00398406374501992,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0034109,homotypic cell-cell adhesion,436,0.352992494710646,1.61050573163734,0.00398406374501992,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0034110,regulation of homotypic cell-cell adhesion,268,0.349959330281964,1.51876753763829,0.00398406374501992,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0051249,regulation of lymphocyte activation,332,0.333110921319155,1.47663381154469,0.00398406374501992,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0070838,divalent metal ion transport,306,0.33506949567658,1.50160643239122,0.00398406374501992,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0072511,divalent inorganic cation transport,307,0.337743543276791,1.51297565391302,0.00398406374501992,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1903533,regulation of protein targeting,256,0.340186577222589,1.46707340540393,0.00398406374501992,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0007159,leukocyte cell-cell adhesion,414,0.343231479474336,1.57159860517092,0.004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0030260,entry into host cell,103,0.50230342581589,1.95004619596305,0.004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0030324,lung development,140,0.376892438052225,1.51034067998097,0.004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0031349,positive regulation of defense response,383,0.311940154208075,1.39737474856832,0.004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0043491,protein kinase B signaling,117,0.420345349691462,1.64469847106658,0.004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0043627,response to estrogen,161,0.344943622902334,1.42781231200744,0.004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0044409,entry into host,103,0.50230342581589,1.95004619596305,0.004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0050863,regulation of T cell activation,253,0.348049169803866,1.50143159899838,0.004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0051806,entry into cell of other organism involved in symbiotic interaction,103,0.50230342581589,1.95004619596305,0.004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0051828,entry into other organism involved in symbiotic interaction,103,0.50230342581589,1.95004619596305,0.004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0052126,movement in host environment,103,0.50230342581589,1.95004619596305,0.004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0052192,movement in environment of other organism involved in symbiotic interaction,103,0.50230342581589,1.95004619596305,0.004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1902105,regulation of leukocyte differentiation,202,0.403414200596487,1.71592579565314,0.004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1904029,regulation of cyclin-dependent protein kinase activity,119,0.387951753630732,1.57339415693341,0.004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0001525,angiogenesis,316,0.341334393570437,1.50404557270559,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002218,activation of innate immune response,271,0.340752030600277,1.49590146506448,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002696,positive regulation of leukocyte activation,254,0.337445697545999,1.46869642905015,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006414,translational elongation,203,-0.366932173875137,-1.55483410592109,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006415,translational termination,177,-0.373914351006577,-1.56057539951344,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006997,nucleus organization,117,-0.418553248525727,-1.68185957957311,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0008033,tRNA processing,140,-0.467757530540751,-1.90401155549265,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0010769,regulation of cell morphogenesis involved in differentiation,253,0.315271903827017,1.36505852451722,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0030036,actin cytoskeleton organization,439,0.339673221120808,1.5443885486448,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0032543,mitochondrial translation,113,-0.491045600561377,-1.90781319332289,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0032944,regulation of mononuclear cell proliferation,175,0.363902366489841,1.50694080202092,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0034329,cell junction assembly,185,0.358389483058235,1.49625428433804,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0045089,positive regulation of innate immune response,312,0.326584292924286,1.44527346206403,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0050900,leukocyte migration,282,0.348461561844519,1.53815291817605,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0070486,leukocyte aggregation,389,0.34324215916721,1.54911318951056,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0070588,calcium ion transmembrane transport,186,0.350378091054229,1.47811166026682,0.00401606425702811,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002237,response to molecule of bacterial origin,284,0.384192842581699,1.68923641496711,0.00403225806451613,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002573,myeloid leukocyte differentiation,165,0.37512312288611,1.55530243326521,0.00403225806451613,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0032387,negative regulation of intracellular transport,131,0.396782452780328,1.59282075151098,0.00403225806451613,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0034470,ncRNA processing,318,-0.471691217676209,-2.10100302863171,0.00403225806451613,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0045619,regulation of lymphocyte differentiation,119,0.377658472804689,1.4928377225392,0.00403225806451613,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0051251,positive regulation of lymphocyte activation,231,0.348629100160294,1.50450780642869,0.00403225806451613,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002758,innate immune response-activating signal transduction,265,0.351355408333066,1.53405505820522,0.00404858299595142,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0010770,positive regulation of cell morphogenesis involved in differentiation,130,0.398010942592947,1.57559744367683,0.00404858299595142,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0045785,positive regulation of cell adhesion,305,0.361523735173282,1.59985040658849,0.00404858299595142,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006909,phagocytosis,188,0.450583029614309,1.90606674562105,0.0040650406504065,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0022604,regulation of cell morphogenesis,403,0.350396747518889,1.57779932315364,0.0040650406504065,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0045834,positive regulation of lipid metabolic process,102,0.380626795455409,1.47856528490577,0.0040650406504065,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0090305,nucleic acid phosphodiester bond hydrolysis,229,-0.424521519049705,-1.83915476150566,0.0040650406504065,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0042098,T cell proliferation,158,0.371869756676857,1.5240854003378,0.00408163265306122,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0043062,extracellular structure organization,248,0.42703068567677,1.86594425869328,0.00408163265306122,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0071216,cellular response to biotic stimulus,163,0.430835582182426,1.78488377933995,0.00408163265306122,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0071219,cellular response to molecule of bacterial origin,146,0.441049568165722,1.80106059540264,0.00408163265306122,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0090501,RNA phosphodiester bond hydrolysis,103,-0.437354598585494,-1.69272011513228,0.00408163265306122,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006399,tRNA metabolic process,190,-0.466432354744805,-1.98139204622584,0.00409836065573771,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0022407,regulation of cell-cell adhesion,320,0.368856193152558,1.63664002021119,0.00409836065573771,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0030198,extracellular matrix organization,247,0.432071686066881,1.88519387095368,0.00409836065573771,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0050954,sensory perception of mechanical stimulus,101,0.387484531072721,1.49035361622152,0.00409836065573771,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0015992,proton transport,122,0.445010968705528,1.76365936887021,0.00411522633744856,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0050867,positive regulation of cell activation,261,0.33459242581295,1.45618216804672,0.00411522633744856,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0071229,cellular response to acid chemical,136,0.403589640403041,1.62861938779151,0.00411522633744856,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:1903037,regulation of leukocyte cell-cell adhesion,260,0.34782584859446,1.50171231367912,0.00411522633744856,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002224,toll-like receptor signaling pathway,148,0.385513846699097,1.60128970594374,0.00413223140495868,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0006818,hydrogen transport,124,0.446234413786693,1.76905599091204,0.00413223140495868,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0007067,mitotic nuclear division,387,-0.329787725180511,-1.50049980808024,0.00413223140495868,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,114,0.412622268499614,1.60826674523381,0.00413223140495868,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0071222,cellular response to lipopolysaccharide,139,0.463319589238499,1.86345417575029,0.004149377593361,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002253,activation of immune response,472,0.325155982494279,1.48731583512047,0.00416666666666667,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0002757,immune response-activating signal transduction,433,0.32315862118093,1.47542643237531,0.00416666666666667,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0034660,ncRNA metabolic process,452,-0.428739820960217,-1.98792036308796,0.00418410041841004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0070925,organelle assembly,493,-0.310388285325931,-1.42614822248402,0.00418410041841004,0.0160687260749577,0.00813705232546335,BP,mono-sp-vs-hc
GO:0018205,peptidyl-lysine modification,358,-0.291529541784797,-1.31359697589176,0.00421940928270042,0.0161470680323836,0.00817672395866439,BP,mono-sp-vs-hc
GO:0044782,cilium organization,171,-0.35549098519566,-1.46630278657482,0.00423728813559322,0.0161583910241108,0.00818245781558216,BP,mono-sp-vs-hc
GO:0000280,nuclear division,474,-0.316348421580379,-1.45647592507559,0.00427350427350427,0.0161825354133046,0.00819468430804463,BP,mono-sp-vs-hc
GO:0007051,spindle organization,121,-0.408645924862906,-1.6229497573841,0.00427350427350427,0.0161825354133046,0.00819468430804463,BP,mono-sp-vs-hc
GO:0002221,pattern recognition receptor signaling pathway,176,0.361995202607454,1.52828586806398,0.00431034482758621,0.0162651688093236,0.00823652908553976,BP,mono-sp-vs-hc
GO:0006397,mRNA processing,413,-0.306518358222484,-1.39742951049685,0.00434782608695652,0.0163077849721428,0.00825810951109139,BP,mono-sp-vs-hc
GO:0009451,RNA modification,116,-0.484131581099576,-1.94450823009143,0.00436681222707424,0.0163077849721428,0.00825810951109139,BP,mono-sp-vs-hc
GO:0071826,ribonucleoprotein complex subunit organization,196,-0.356537171569432,-1.49344392541466,0.00436681222707424,0.0163077849721428,0.00825810951109139,BP,mono-sp-vs-hc
GO:0043687,post-translational protein modification,425,-0.280031039118965,-1.28847489042903,0.00442477876106195,0.0164674755952924,0.0083389753464036,BP,mono-sp-vs-hc
GO:0009306,protein secretion,376,0.293978006029454,1.32413853612329,0.00701754385964912,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0048729,tissue morphogenesis,426,0.28102244124048,1.27692967153135,0.00704225352112676,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0061138,morphogenesis of a branching epithelium,124,0.376473747669247,1.47809932780678,0.0072202166064982,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0071356,cellular response to tumor necrosis factor,214,0.311363337455561,1.33959727531697,0.0072463768115942,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0030100,regulation of endocytosis,165,0.353538308429929,1.4807002564574,0.00727272727272727,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0032412,regulation of ion transmembrane transporter activity,129,0.357731589726167,1.43539269590807,0.00727272727272727,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0050890,cognition,175,0.343090263611207,1.44011542680079,0.00727272727272727,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0055076,transition metal ion homeostasis,117,0.382857370134254,1.53066288699434,0.00727272727272727,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0031669,cellular response to nutrient levels,137,0.369239614204976,1.47524302967311,0.0072992700729927,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0001763,morphogenesis of a branching structure,135,0.384237157985498,1.52290872038679,0.00732600732600733,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0002223,stimulatory C-type lectin receptor signaling pathway,118,0.383100573943028,1.51103051408264,0.00732600732600733,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0008637,apoptotic mitochondrial changes,109,0.406126637066931,1.58942132210078,0.00735294117647059,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0048732,gland development,330,0.326012808223875,1.45733790389885,0.00738007380073801,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:1903531,negative regulation of secretion by cell,127,0.360463106798414,1.44660790370023,0.00740740740740741,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0022898,regulation of transmembrane transporter activity,132,0.350464476071494,1.40544009151728,0.00743494423791822,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0009144,purine nucleoside triphosphate metabolic process,201,0.345738388445601,1.46374667650332,0.00749063670411985,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0060348,bone development,120,0.378992598267475,1.49651159351639,0.00749063670411985,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0031348,negative regulation of defense response,120,0.386130985514997,1.53634769354382,0.0075187969924812,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:1901342,regulation of vasculature development,170,0.351151013719474,1.46876916629652,0.0075187969924812,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0009612,response to mechanical stimulus,161,0.378155936540492,1.59260325013374,0.00754716981132075,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0045666,positive regulation of neuron differentiation,217,0.343237758219695,1.45425100721526,0.00754716981132075,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0045765,regulation of angiogenesis,159,0.339433565773869,1.41100207764431,0.00754716981132075,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:1903707,negative regulation of hemopoiesis,106,0.402878623452299,1.57376478214978,0.00760456273764259,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0044706,multi-multicellular organism process,175,0.341873662906595,1.4159714007115,0.00763358778625954,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:1903708,positive regulation of hemopoiesis,144,0.372034962417238,1.51410131538331,0.00766283524904215,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0030099,myeloid cell differentiation,302,0.305953440675122,1.35153499228194,0.00769230769230769,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0046651,lymphocyte proliferation,218,0.329297333596369,1.41207418526658,0.00769230769230769,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0030098,lymphocyte differentiation,261,0.317631510566313,1.37846962079151,0.00772200772200772,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0061061,muscle structure development,401,0.324635784981684,1.45428840565357,0.00772200772200772,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0071560,cellular response to transforming growth factor beta stimulus,204,0.315562967058644,1.33683755607894,0.00772200772200772,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0009141,nucleoside triphosphate metabolic process,217,0.334075214653078,1.4138801926943,0.00775193798449612,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0043433,negative regulation of sequence-specific DNA binding transcription factor activity,119,0.375845178657781,1.47705799161329,0.00775193798449612,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0007162,negative regulation of cell adhesion,187,0.353142065395788,1.48262216928651,0.00778210116731518,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0045444,fat cell differentiation,157,0.362993302625414,1.49032067025605,0.00778210116731518,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0046034,ATP metabolic process,181,0.355434116635995,1.46713423442175,0.0078125,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0051048,negative regulation of secretion,142,0.370604541742476,1.50805378009146,0.00784313725490196,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0014031,mesenchymal cell development,117,0.392261652415624,1.54361946455416,0.0078740157480315,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0001889,liver development,117,0.375559125223712,1.47607556660192,0.00790513833992095,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0007600,sensory perception,334,0.291903870619503,1.31539117169792,0.00790513833992095,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0032956,regulation of actin cytoskeleton organization,229,0.341388272029346,1.46771659230532,0.00790513833992095,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0035637,multicellular organismal signaling,119,0.389793692836014,1.54894113579972,0.00790513833992095,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0042692,muscle cell differentiation,257,0.335662156029803,1.4396976745103,0.00790513833992095,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0072507,divalent inorganic cation homeostasis,289,0.311128170838069,1.37053187433141,0.00790513833992095,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0030595,leukocyte chemotaxis,138,0.364263484182364,1.49065894297714,0.00793650793650794,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0002429,immune response-activating cell surface receptor signaling pathway,298,0.322325921486131,1.42097845877607,0.00796812749003984,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,197,0.323284758775756,1.3677177631904,0.00796812749003984,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0090002,establishment of protein localization to plasma membrane,114,0.369580496108741,1.44040835487872,0.00796812749003984,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0045637,regulation of myeloid cell differentiation,156,0.36980868708978,1.52238608797321,0.008,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0030278,regulation of ossification,131,0.386749219323042,1.56549005154327,0.00803212851405622,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0032943,mononuclear cell proliferation,221,0.328215556253547,1.39636440929418,0.00803212851405622,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:2001236,regulation of extrinsic apoptotic signaling pathway,132,0.377618429159305,1.51307706386713,0.00803212851405622,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0001678,cellular glucose homeostasis,101,0.405800094945652,1.57657925840465,0.00806451612903226,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0048864,stem cell development,121,0.37665735532935,1.48723011657638,0.00806451612903226,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0051495,positive regulation of cytoskeleton organization,160,0.325928502556296,1.3551547598493,0.00806451612903226,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0006839,mitochondrial transport,256,0.317171695638706,1.36862137780474,0.00809716599190283,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0030323,respiratory tube development,144,0.372261358771947,1.49254660166539,0.00809716599190283,0.0252715584127688,0.0127972803936945,BP,mono-sp-vs-hc
GO:0008154,actin polymerization or depolymerization,156,0.370315850200432,1.50727772055703,0.00816326530612245,0.0252836531727133,0.0128034050668063,BP,mono-sp-vs-hc
GO:0043241,protein complex disassembly,290,-0.312018285053842,-1.38158408870926,0.00819672131147541,0.0252836531727133,0.0128034050668063,BP,mono-sp-vs-hc
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,160,0.378210249484505,1.54096377270553,0.00819672131147541,0.0252836531727133,0.0128034050668063,BP,mono-sp-vs-hc
GO:0051817,modification of morphology or physiology of other organism involved in symbiotic interaction,106,-0.413441033692874,-1.60494507854729,0.00823045267489712,0.0252836531727133,0.0128034050668063,BP,mono-sp-vs-hc
GO:0000819,sister chromatid segregation,143,-0.359695385142557,-1.47089153165403,0.00826446280991736,0.0252836531727133,0.0128034050668063,BP,mono-sp-vs-hc
GO:0018108,peptidyl-tyrosine phosphorylation,249,0.321766079404347,1.39257529538017,0.00826446280991736,0.0252836531727133,0.0128034050668063,BP,mono-sp-vs-hc
GO:0042384,cilium assembly,155,-0.354550129890428,-1.44005260770944,0.00826446280991736,0.0252836531727133,0.0128034050668063,BP,mono-sp-vs-hc
GO:0018212,peptidyl-tyrosine modification,251,0.33012272839807,1.42961606531454,0.00840336134453781,0.0256361699609421,0.0129819162653942,BP,mono-sp-vs-hc
GO:0006310,DNA recombination,264,-0.316457765016265,-1.39879905436247,0.00843881856540084,0.0256720238941829,0.0130000723612473,BP,mono-sp-vs-hc
GO:0006413,translational initiation,262,-0.306485578853427,-1.32796274289071,0.00854700854700855,0.0259283200459671,0.0131298583310967,BP,mono-sp-vs-hc
GO:0007266,Rho protein signal transduction,129,0.354486130730586,1.38760554194489,0.00858369098712446,0.025933908045977,0.0131326880419439,BP,mono-sp-vs-hc
GO:0006281,DNA repair,467,-0.270120178967535,-1.23750081816722,0.00862068965517241,0.025933908045977,0.0131326880419439,BP,mono-sp-vs-hc
GO:0008380,RNA splicing,353,-0.304538819686811,-1.36975504295034,0.00862068965517241,0.025933908045977,0.0131326880419439,BP,mono-sp-vs-hc
GO:0098813,nuclear chromosome segregation,186,-0.329349149780359,-1.37243669729844,0.00925925925925926,0.0277777777777778,0.01406640639765,BP,mono-sp-vs-hc
GO:1903651,positive regulation of cytoplasmic transport,222,0.31202876953396,1.33618176866486,0.010752688172043,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0010810,regulation of cell-substrate adhesion,134,0.371283020043072,1.50661627193458,0.0109090909090909,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0000302,response to reactive oxygen species,192,0.348475570473776,1.4505594068278,0.0109489051094891,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0048638,regulation of developmental growth,219,0.340355749922736,1.42702911654849,0.010989010989011,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0051962,positive regulation of nervous system development,299,0.298871727517639,1.32115419038084,0.010989010989011,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0006979,response to oxidative stress,336,0.302582433390303,1.34640531740652,0.011070110701107,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0009416,response to light stimulus,278,0.301992047360479,1.32838409607389,0.011070110701107,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0045927,positive regulation of growth,178,0.347201362207236,1.41970536902213,0.011070110701107,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:1903828,negative regulation of cellular protein localization,124,0.364286952131074,1.45614643218036,0.011070110701107,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0034599,cellular response to oxidative stress,201,0.334945340957811,1.41780178027553,0.0111111111111111,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0034612,response to tumor necrosis factor,234,0.304908245651991,1.3204160057143,0.0111111111111111,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0010976,positive regulation of neuron projection development,170,0.345925618488681,1.42494309416705,0.0111524163568773,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0007610,behavior,494,0.284572071577607,1.31849629090301,0.0112359550561798,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0050769,positive regulation of neurogenesis,268,0.313440156048595,1.36022286694687,0.0112359550561798,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0051216,cartilage development,112,0.391199029057038,1.54092221816573,0.0112359550561798,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0042542,response to hydrogen peroxide,112,0.387800372798191,1.52093970602786,0.0112781954887218,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:1990778,protein localization to cell periphery,175,0.329049594424273,1.36763334575582,0.0112781954887218,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,250,0.302303448581038,1.30745521738428,0.0113207547169811,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0000187,activation of MAPK activity,116,0.378499221914055,1.47793563149924,0.0113636363636364,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0060541,respiratory system development,162,0.352307043631229,1.4478382328693,0.0113636363636364,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0009187,cyclic nucleotide metabolic process,116,0.35871156533562,1.41751173622262,0.0114503816793893,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0016051,carbohydrate biosynthetic process,168,0.333520401749182,1.36489142785458,0.0114503816793893,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0008064,regulation of actin polymerization or depolymerization,136,0.359759301184967,1.46117091744735,0.0114942528735632,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0072659,protein localization to plasma membrane,173,0.333553345817286,1.378641770744,0.0114942528735632,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0030832,regulation of actin filament length,137,0.357025656321923,1.44847187282161,0.0115830115830116,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0051092,positive regulation of NF-kappaB transcription factor activity,112,0.358774832767084,1.41419751653772,0.0115830115830116,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,220,0.332029147456336,1.42249059165994,0.0116279069767442,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0006874,cellular calcium ion homeostasis,259,0.296981579826905,1.30103702135813,0.0116731517509728,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0001701,in utero embryonic development,294,0.298619329397278,1.31306478816689,0.01171875,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0006261,DNA-dependent DNA replication,119,-0.354066178979886,-1.42190499068524,0.01171875,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0033500,carbohydrate homeostasis,165,0.352033289986416,1.48799943674529,0.01171875,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0042593,glucose homeostasis,165,0.352033289986416,1.48799943674529,0.01171875,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0042129,regulation of T cell proliferation,132,0.354026357973017,1.42668243628405,0.0117647058823529,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0055074,calcium ion homeostasis,266,0.296875251811593,1.3034430775233,0.0117647058823529,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0061008,hepaticobiliary system development,119,0.36139863788565,1.42597250653265,0.0117647058823529,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0032355,response to estradiol,106,0.381526078170976,1.48874679185927,0.0118110236220472,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:1903510,mucopolysaccharide metabolic process,101,0.393566406793297,1.51390642896015,0.0118110236220472,0.032139041665018,0.0162749095664814,BP,mono-sp-vs-hc
GO:0030041,actin filament polymerization,134,0.38211502286084,1.52483132261789,0.0118577075098814,0.0321517634485216,0.0162813517584485,BP,mono-sp-vs-hc
GO:0001959,regulation of cytokine-mediated signaling pathway,118,0.360095138009559,1.43164494770312,0.0119047619047619,0.0321517634485216,0.0162813517584485,BP,mono-sp-vs-hc
GO:0042493,response to drug,336,0.3042439100608,1.36947256049052,0.0119047619047619,0.0321517634485216,0.0162813517584485,BP,mono-sp-vs-hc
GO:0035821,modification of morphology or physiology of other organism,113,-0.397271555212394,-1.5647102160347,0.0119521912350598,0.0321683168316832,0.0162897342365816,BP,mono-sp-vs-hc
GO:0007249,I-kappaB kinase/NF-kappaB signaling,246,0.31778205795191,1.37441525333383,0.012,0.0321683168316832,0.0162897342365816,BP,mono-sp-vs-hc
GO:0060326,cell chemotaxis,177,0.351342635643146,1.47477159217841,0.012,0.0321683168316832,0.0162897342365816,BP,mono-sp-vs-hc
GO:0060759,regulation of response to cytokine stimulus,124,0.361650191954072,1.445120914427,0.0120481927710843,0.0321887136403265,0.0163000629893669,BP,mono-sp-vs-hc
GO:0007259,JAK-STAT cascade,112,0.364381035973867,1.42620694972423,0.0120967741935484,0.0321887136403265,0.0163000629893669,BP,mono-sp-vs-hc
GO:0097696,STAT cascade,112,0.364381035973867,1.42620694972423,0.0120967741935484,0.0321887136403265,0.0163000629893669,BP,mono-sp-vs-hc
GO:0032984,macromolecular complex disassembly,301,-0.305728638546777,-1.35721490618809,0.0122448979591837,0.0324235317598922,0.0164189726849432,BP,mono-sp-vs-hc
GO:0050870,positive regulation of T cell activation,180,0.348177994036601,1.45747998130432,0.0122448979591837,0.0324235317598922,0.0164189726849432,BP,mono-sp-vs-hc
GO:0022618,ribonucleoprotein complex assembly,187,-0.351636766214874,-1.48487574051457,0.0123456790123457,0.0326106594399277,0.0165137323887859,BP,mono-sp-vs-hc
GO:0033673,negative regulation of kinase activity,201,0.321897042057622,1.366366209823,0.0125,0.0328566805549937,0.0166383151763151,BP,mono-sp-vs-hc
GO:1903039,positive regulation of leukocyte cell-cell adhesion,184,0.351375681391786,1.47221120724123,0.0125,0.0328566805549937,0.0166383151763151,BP,mono-sp-vs-hc
GO:0034112,positive regulation of homotypic cell-cell adhesion,183,0.352619917735016,1.47212979558237,0.0125523012552301,0.0328566805549937,0.0166383151763151,BP,mono-sp-vs-hc
GO:0006354,DNA-templated transcription, elongation,127,-0.368419576793239,-1.48542538090405,0.0126050420168067,0.0328566805549937,0.0166383151763151,BP,mono-sp-vs-hc
GO:0070665,positive regulation of leukocyte proliferation,114,0.361500091772303,1.42032024485971,0.0126050420168067,0.0328566805549937,0.0166383151763151,BP,mono-sp-vs-hc
GO:0000070,mitotic sister chromatid segregation,123,-0.379661749885822,-1.50707771703507,0.0126582278481013,0.0328566805549937,0.0166383151763151,BP,mono-sp-vs-hc
GO:0006469,negative regulation of protein kinase activity,189,0.328336343725797,1.3747182324179,0.0126582278481013,0.0328566805549937,0.0166383151763151,BP,mono-sp-vs-hc
GO:0021700,developmental maturation,172,0.314882384310476,1.29726635723034,0.0127118644067797,0.0328566805549937,0.0166383151763151,BP,mono-sp-vs-hc
GO:0022409,positive regulation of cell-cell adhesion,204,0.350367404937325,1.47620454907774,0.0127118644067797,0.0328566805549937,0.0166383151763151,BP,mono-sp-vs-hc
GO:0000377,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,265,-0.308486784567368,-1.34469502146109,0.0135135135135135,0.0347627912948578,0.0176035517953258,BP,mono-sp-vs-hc
GO:0000398,mRNA splicing, via spliceosome,265,-0.308486784567368,-1.34469502146109,0.0135135135135135,0.0347627912948578,0.0176035517953258,BP,mono-sp-vs-hc
GO:0000375,RNA splicing, via transesterification reactions,269,-0.306208348025858,-1.33581559766214,0.0135746606334842,0.0348373399669748,0.0176413025443883,BP,mono-sp-vs-hc
GO:0050708,regulation of protein secretion,312,0.296454522857943,1.30011666088074,0.0145985401459854,0.0373764042035513,0.0189270608835595,BP,mono-sp-vs-hc
GO:0032409,regulation of transporter activity,143,0.338368379476018,1.37782479357175,0.0146520146520147,0.0374248393116318,0.0189515879684698,BP,mono-sp-vs-hc
GO:0035264,multicellular organism growth,122,0.357246365421123,1.42119563370008,0.0148698884758364,0.0378919746337197,0.0191881409186645,BP,mono-sp-vs-hc
GO:0040029,regulation of gene expression, epigenetic,231,0.311484541068806,1.32865012021854,0.0149253731343284,0.037944082404877,0.0192145278057452,BP,mono-sp-vs-hc
GO:0071407,cellular response to organic cyclic compound,410,0.286901417177475,1.3194491943383,0.0150375939849624,0.0381398461023754,0.0193136607079142,BP,mono-sp-vs-hc
GO:0030879,mammary gland development,102,0.389013068020432,1.49675066640221,0.0151515151515152,0.0382496291587201,0.0193692538190146,BP,mono-sp-vs-hc
GO:0043009,chordate embryonic development,453,0.272245244869241,1.25101174955363,0.0151515151515152,0.0382496291587201,0.0193692538190146,BP,mono-sp-vs-hc
GO:0002706,regulation of lymphocyte mediated immunity,101,0.360708644764499,1.39578722697359,0.0152671755725191,0.0384519794070655,0.0194717220888187,BP,mono-sp-vs-hc
GO:1903650,negative regulation of cytoplasmic transport,106,0.377614538272501,1.47989077429355,0.0154440154440154,0.0388071200136165,0.0196515619644207,BP,mono-sp-vs-hc
GO:0019318,hexose metabolic process,224,0.307895113410839,1.30136694034669,0.0155038759689922,0.0388673557278208,0.0196820647657041,BP,mono-sp-vs-hc
GO:0009743,response to carbohydrate,167,0.331964717253897,1.36855861075082,0.015625,0.0390805427251732,0.0197900206636684,BP,mono-sp-vs-hc
GO:0008361,regulation of cell size,137,0.34381196624723,1.3830524690648,0.015748031496063,0.0391172433721014,0.0198086055273994,BP,mono-sp-vs-hc
GO:0030833,regulation of actin filament polymerization,120,0.366009794284568,1.45122348917692,0.015748031496063,0.0391172433721014,0.0198086055273994,BP,mono-sp-vs-hc
GO:0060538,skeletal muscle organ development,115,0.358808680883115,1.40926671157843,0.015748031496063,0.0391172433721014,0.0198086055273994,BP,mono-sp-vs-hc
GO:0007519,skeletal muscle tissue development,110,0.354994405401217,1.38712555661724,0.0158102766798419,0.0391819900326517,0.0198413926296462,BP,mono-sp-vs-hc
GO:0010821,regulation of mitochondrion organization,194,0.338554532985727,1.43040969271747,0.0159362549800797,0.0393818181818182,0.0199425837320574,BP,mono-sp-vs-hc
GO:0030307,positive regulation of cell growth,114,0.368250769100814,1.42133747113669,0.016,0.0393818181818182,0.0199425837320574,BP,mono-sp-vs-hc
GO:0051168,nuclear export,149,-0.340159673744988,-1.38051307738168,0.016,0.0393818181818182,0.0199425837320574,BP,mono-sp-vs-hc
GO:0030203,glycosaminoglycan metabolic process,131,0.348239598518168,1.38582422092603,0.0161290322580645,0.039590206633096,0.0200481096912505,BP,mono-sp-vs-hc
GO:0019882,antigen processing and presentation,219,0.31606106409171,1.35785192242073,0.0161943319838057,0.039590206633096,0.0200481096912505,BP,mono-sp-vs-hc
GO:0071346,cellular response to interferon-gamma,117,0.346713910806103,1.37583549191125,0.0161943319838057,0.039590206633096,0.0200481096912505,BP,mono-sp-vs-hc
GO:0006022,aminoglycan metabolic process,136,0.346959069781132,1.37975340999316,0.0163265306122449,0.0398234969663541,0.0201662457301555,BP,mono-sp-vs-hc
GO:0043624,cellular protein complex disassembly,262,-0.302380699251583,-1.3213456864256,0.016597510373444,0.0403029231713898,0.0204090226683132,BP,mono-sp-vs-hc
GO:0060271,cilium morphogenesis,184,-0.314955081434612,-1.31098233350518,0.016597510373444,0.0403029231713898,0.0204090226683132,BP,mono-sp-vs-hc
GO:0007059,chromosome segregation,250,-0.298548107020821,-1.28441206944105,0.0175438596491228,0.0425055928411633,0.0215244339507665,BP,mono-sp-vs-hc
GO:2001251,negative regulation of chromosome organization,116,-0.354068202383109,-1.39512918901422,0.0178571428571429,0.0431680484693878,0.021859895273899,BP,mono-sp-vs-hc
GO:0038127,ERBB signaling pathway,315,0.302518336296986,1.33465659022368,0.0181818181818182,0.043855031382871,0.0222077769844737,BP,mono-sp-vs-hc
GO:0007173,epidermal growth factor receptor signaling pathway,310,0.302127672310564,1.32923691799552,0.0182481751824818,0.0439172749391727,0.0222392965381824,BP,mono-sp-vs-hc
GO:0048568,embryonic organ development,288,0.299336127719584,1.31373666069091,0.0183150183150183,0.0439804098340684,0.0222712674574035,BP,mono-sp-vs-hc
GO:0009314,response to radiation,393,0.282267258606143,1.28092877596524,0.0185185185185185,0.0443706981317601,0.0224689057944764,BP,mono-sp-vs-hc
GO:1904018,positive regulation of vasculature development,103,0.35163405895982,1.3620457508286,0.0185873605947955,0.0444373322829218,0.0225026487042837,BP,mono-sp-vs-hc
GO:0009792,embryo development ending in birth or egg hatching,458,0.271088669768004,1.24672610707283,0.0186567164179104,0.0445048984154119,0.0225368635607033,BP,mono-sp-vs-hc
GO:0042742,defense response to bacterium,138,0.348372860784536,1.39295292319997,0.0188679245283019,0.0449098071739581,0.0227419055621638,BP,mono-sp-vs-hc
GO:0044708,single-organism behavior,275,0.301961001841764,1.33364576094434,0.0191570881226054,0.0454980842911877,0.0230398035823578,BP,mono-sp-vs-hc
GO:0045596,negative regulation of cell differentiation,430,0.272017929150485,1.24292280806268,0.0192307692307692,0.0455731358357179,0.0230778089812986,BP,mono-sp-vs-hc
GO:1903035,negative regulation of response to wounding,121,0.361579778427055,1.42074845443938,0.0193798449612403,0.0458261399410988,0.0232059278896948,BP,mono-sp-vs-hc
GO:0051493,regulation of cytoskeleton organization,351,0.27595877195922,1.24286608812818,0.01953125,0.0460835375816993,0.0233362716431602,BP,mono-sp-vs-hc
GO:0002703,regulation of leukocyte mediated immunity,137,0.351553281763313,1.41733958949512,0.0196078431372549,0.0461636828644501,0.0233768564634092,BP,mono-sp-vs-hc
GO:1901136,carbohydrate derivative catabolic process,148,0.334751969482887,1.33856103813923,0.0196850393700787,0.0462448972620288,0.0234179826733897,BP,mono-sp-vs-hc
GO:0071322,cellular response to carbohydrate stimulus,105,0.370713774237529,1.4360586295541,0.0198412698412698,0.0465110286538858,0.0235527491166589,BP,mono-sp-vs-hc
GO:0048545,response to steroid hormone,396,0.285983734941258,1.29924155175066,0.02,0.0467818574514039,0.0236898942821416,BP,mono-sp-vs-hc
GO:0010466,negative regulation of peptidase activity,160,0.322146567506906,1.31269510359775,0.0202429149797571,0.0471464019851117,0.023874496218344,BP,mono-sp-vs-hc
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,107,0.364094613318806,1.40385538921312,0.0202429149797571,0.0471464019851117,0.023874496218344,BP,mono-sp-vs-hc
GO:0035295,tube development,436,0.278863734892523,1.27281477044261,0.021505376344086,0.0499792330056763,0.0253090153044247,BP,mono-sp-vs-hc
GO:0070374,positive regulation of ERK1 and ERK2 cascade,114,0.360446403150085,1.41434206874097,0.0220588235294118,0.0511556871142461,0.0259047606420005,BP,mono-sp-vs-hc
GO:0002695,negative regulation of leukocyte activation,119,0.353713280029219,1.39295650628661,0.0223048327137546,0.0516156705747784,0.0261376919565141,BP,mono-sp-vs-hc
GO:0007611,learning or memory,153,0.32145415827441,1.31688681792363,0.0224719101123595,0.0517810184078413,0.0262214225499201,BP,mono-sp-vs-hc
GO:0046822,regulation of nucleocytoplasmic transport,187,0.30460654054165,1.28098727984211,0.0224719101123595,0.0517810184078413,0.0262214225499201,BP,mono-sp-vs-hc
GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,169,0.327636364300299,1.36561074415281,0.0225563909774436,0.0518653321201092,0.0262641182238197,BP,mono-sp-vs-hc
GO:0032102,negative regulation of response to external stimulus,203,0.316412934863897,1.34212455686543,0.0226415094339623,0.0519507515190278,0.0263073738070793,BP,mono-sp-vs-hc
GO:0050866,negative regulation of cell activation,132,0.356620689541003,1.41642818043772,0.0228136882129278,0.052074317696613,0.0263699465616323,BP,mono-sp-vs-hc
GO:0014706,striated muscle tissue development,226,0.31956464837762,1.34476464518945,0.0229007633587786,0.052074317696613,0.0263699465616323,BP,mono-sp-vs-hc
GO:0042306,regulation of protein import into nucleus,150,0.330211171247411,1.34214024859392,0.0229007633587786,0.052074317696613,0.0263699465616323,BP,mono-sp-vs-hc
GO:0044724,single-organism carbohydrate catabolic process,114,0.356320323648879,1.38820362051247,0.0229007633587786,0.052074317696613,0.0263699465616323,BP,mono-sp-vs-hc
GO:0033044,regulation of chromosome organization,261,-0.305728380896717,-1.33109139102574,0.0229357798165138,0.052074317696613,0.0263699465616323,BP,mono-sp-vs-hc
GO:0001649,osteoblast differentiation,158,0.353520953316261,1.44418132759858,0.0232558139534884,0.0525804728844006,0.0266262588062135,BP,mono-sp-vs-hc
GO:0060537,muscle tissue development,234,0.314276230384807,1.32722581320656,0.0232558139534884,0.0525804728844006,0.0266262588062135,BP,mono-sp-vs-hc
GO:0006109,regulation of carbohydrate metabolic process,135,0.345315341821799,1.36637537993268,0.0235294117647059,0.0530882352941177,0.0268833849329205,BP,mono-sp-vs-hc
GO:0010951,negative regulation of endopeptidase activity,152,0.330060199983233,1.34253855515655,0.024,0.0540297837311981,0.0273601762394462,BP,mono-sp-vs-hc
GO:0006869,lipid transport,216,0.305731607713806,1.3037059631745,0.0240963855421687,0.0540297837311981,0.0273601762394462,BP,mono-sp-vs-hc
GO:0051098,regulation of binding,239,0.302998342639403,1.31329688792484,0.0240963855421687,0.0540297837311981,0.0273601762394462,BP,mono-sp-vs-hc
GO:0010822,positive regulation of mitochondrion organization,145,0.340352776861654,1.38177507624786,0.0241935483870968,0.0541355638496401,0.0274137423002989,BP,mono-sp-vs-hc
GO:0005996,monosaccharide metabolic process,247,0.301488914176085,1.30459355343657,0.0249110320284698,0.0556260777048098,0.0281685245509121,BP,mono-sp-vs-hc
GO:0050671,positive regulation of lymphocyte proliferation,110,0.344395972121434,1.35741548689634,0.025,0.0557098765432099,0.0282109594975092,BP,mono-sp-vs-hc
GO:0032946,positive regulation of mononuclear cell proliferation,112,0.342983035480027,1.34486137362933,0.0253164556962025,0.0562992228315962,0.0285093989359592,BP,mono-sp-vs-hc
GO:0060560,developmental growth involved in morphogenesis,156,0.330730738800081,1.3388986373149,0.0257352941176471,0.0571133678881389,0.02892167436431,BP,mono-sp-vs-hc
GO:0010948,negative regulation of cell cycle process,231,-0.304867109729861,-1.32210976676409,0.0258620689655172,0.0572773429236302,0.0290047097858885,BP,mono-sp-vs-hc
GO:0010631,epithelial cell migration,171,0.308256637113848,1.27937138896763,0.0260223048327138,0.0573974666676762,0.0290655393243517,BP,mono-sp-vs-hc
GO:0090132,epithelium migration,171,0.308256637113848,1.27937138896763,0.0260223048327138,0.0573974666676762,0.0290655393243517,BP,mono-sp-vs-hc
GO:0002697,regulation of immune effector process,358,0.278245748383494,1.24540035982204,0.0262172284644195,0.0575928162818789,0.0291644625386197,BP,mono-sp-vs-hc
GO:0043270,positive regulation of ion transport,164,0.328819390625292,1.36353544721395,0.0262172284644195,0.0575928162818789,0.0291644625386197,BP,mono-sp-vs-hc
GO:0016052,carbohydrate catabolic process,120,0.355781997167659,1.38815780815621,0.027027027027027,0.0591318591318591,0.0299438194175036,BP,mono-sp-vs-hc
GO:0051250,negative regulation of lymphocyte activation,104,0.371549362960528,1.43118290874265,0.027027027027027,0.0591318591318591,0.0299438194175036,BP,mono-sp-vs-hc
GO:0031099,regeneration,136,0.33602248502277,1.35354153208076,0.0274509803921569,0.059938330170778,0.0303522087952329,BP,mono-sp-vs-hc
GO:0007565,female pregnancy,148,0.325025371370834,1.30107299287978,0.0276679841897233,0.0602905973389746,0.0305305935885754,BP,mono-sp-vs-hc
GO:0048705,skeletal system morphogenesis,115,0.32787631265373,1.28222589885404,0.028,0.0607695390781563,0.030773125197764,BP,mono-sp-vs-hc
GO:0097191,extrinsic apoptotic signaling pathway,201,0.31189337768976,1.32236924430207,0.028,0.0607695390781563,0.030773125197764,BP,mono-sp-vs-hc
GO:0006289,nucleotide-excision repair,115,-0.351546837589182,-1.38827822402155,0.0292887029288703,0.0634393305439331,0.0321250825809293,BP,mono-sp-vs-hc
GO:0009152,purine ribonucleotide biosynthetic process,166,0.310472655963407,1.29607629287695,0.029520295202952,0.0638133327441059,0.0323144737908142,BP,mono-sp-vs-hc
GO:0030217,T cell differentiation,188,0.313412524040857,1.30648413883595,0.0296296296296296,0.0639220894200974,0.0323695471525205,BP,mono-sp-vs-hc
GO:0007517,muscle organ development,231,0.306300798143008,1.3004359713417,0.0297397769516729,0.0640028366908229,0.0324104368138394,BP,mono-sp-vs-hc
GO:0052548,regulation of endopeptidase activity,272,0.280627030461998,1.23338407201812,0.0298507462686567,0.0640028366908229,0.0324104368138394,BP,mono-sp-vs-hc
GO:0009126,purine nucleoside monophosphate metabolic process,217,0.308137527985917,1.30722500574598,0.0299625468164794,0.0640028366908229,0.0324104368138394,BP,mono-sp-vs-hc
GO:0009167,purine ribonucleoside monophosphate metabolic process,217,0.308137527985917,1.30722500574598,0.0299625468164794,0.0640028366908229,0.0324104368138394,BP,mono-sp-vs-hc
GO:0090130,tissue migration,173,0.307782589270679,1.28134451085735,0.0299625468164794,0.0640028366908229,0.0324104368138394,BP,mono-sp-vs-hc
GO:0010927,cellular component assembly involved in morphogenesis,221,-0.297867755402324,-1.27917924655156,0.0308880308880309,0.0657205057990913,0.0332802483562488,BP,mono-sp-vs-hc
GO:2000146,negative regulation of cell motility,153,0.319604692908586,1.30451704345051,0.0308880308880309,0.0657205057990913,0.0332802483562488,BP,mono-sp-vs-hc
GO:0040013,negative regulation of locomotion,191,0.303760778038687,1.27666941595248,0.03125,0.0662304305283757,0.0335384694613245,BP,mono-sp-vs-hc
GO:0052547,regulation of peptidase activity,289,0.280432238388012,1.2352282309121,0.03125,0.0662304305283757,0.0335384694613245,BP,mono-sp-vs-hc
GO:0009117,nucleotide metabolic process,499,0.266239713107865,1.22460184370815,0.0313588850174216,0.0663313915505226,0.0335895951769668,BP,mono-sp-vs-hc
GO:0097529,myeloid leukocyte migration,117,0.341377430233307,1.36146383969595,0.0318725099601594,0.067286409915892,0.034073207528969,BP,mono-sp-vs-hc
GO:0008202,steroid metabolic process,204,0.308076411341792,1.31255113198119,0.0321285140562249,0.0676949041301392,0.0342800651716018,BP,mono-sp-vs-hc
GO:0051099,positive regulation of binding,108,0.345246814495307,1.35373858132642,0.0326530612244898,0.0685563566027783,0.0347162966322083,BP,mono-sp-vs-hc
GO:0006006,glucose metabolic process,192,0.31550898116495,1.32190450331341,0.0327272727272727,0.0685563566027783,0.0347162966322083,BP,mono-sp-vs-hc
GO:0090316,positive regulation of intracellular protein transport,206,0.302096382236322,1.28101498300237,0.0327272727272727,0.0685563566027783,0.0347162966322083,BP,mono-sp-vs-hc
GO:0009161,ribonucleoside monophosphate metabolic process,227,0.303745408031451,1.29353547820555,0.033457249070632,0.0699501944855105,0.0354221230762025,BP,mono-sp-vs-hc
GO:0000226,microtubule cytoskeleton organization,364,-0.272554157910885,-1.23232537292584,0.0338983050847458,0.070732946298984,0.0358185012604079,BP,mono-sp-vs-hc
GO:0090287,regulation of cellular response to growth factor stimulus,179,0.326945507424739,1.35991111975781,0.0339622641509434,0.070732946298984,0.0358185012604079,BP,mono-sp-vs-hc
GO:0042326,negative regulation of phosphorylation,347,0.270207612974635,1.22084454168866,0.0344827586206897,0.0716791316433914,0.0362976406533575,BP,mono-sp-vs-hc
GO:0016054,organic acid catabolic process,189,-0.30816319570063,-1.29932990398245,0.0352422907488987,0.0729778219523084,0.0369552852574745,BP,mono-sp-vs-hc
GO:0046395,carboxylic acid catabolic process,189,-0.30816319570063,-1.29932990398245,0.0352422907488987,0.0729778219523084,0.0369552852574745,BP,mono-sp-vs-hc
GO:1903747,regulation of establishment of protein localization to mitochondrion,112,0.345288963824743,1.35589577120766,0.0357142857142857,0.0738140676117775,0.0373787522240716,BP,mono-sp-vs-hc
GO:0010675,regulation of cellular carbohydrate metabolic process,127,0.337110508811826,1.32818050156963,0.0358565737051793,0.0738263675336676,0.0373849807892704,BP,mono-sp-vs-hc
GO:0044772,mitotic cell cycle phase transition,443,-0.255628927149134,-1.193241573672,0.0358565737051793,0.0738263675336676,0.0373849807892704,BP,mono-sp-vs-hc
GO:0034341,response to interferon-gamma,138,0.331104646784187,1.34408428427412,0.036734693877551,0.0754908414978895,0.0382278548091563,BP,mono-sp-vs-hc
GO:0046128,purine ribonucleoside metabolic process,284,0.286435717005952,1.25341111689536,0.0380228136882129,0.077989975803664,0.0394933930055003,BP,mono-sp-vs-hc
GO:0031032,actomyosin structure organization,113,0.313714344803792,1.25112744562075,0.0383141762452107,0.0782910431576664,0.039645850692661,BP,mono-sp-vs-hc
GO:0051701,interaction with host,171,0.318533966739431,1.31472885948118,0.0383141762452107,0.0782910431576664,0.039645850692661,BP,mono-sp-vs-hc
GO:0006814,sodium ion transport,124,0.340789870817882,1.32875489762074,0.0387596899224806,0.0790522489379407,0.0400313181675338,BP,mono-sp-vs-hc
GO:0032259,methylation,310,-0.279905963167314,-1.24254620833374,0.0391304347826087,0.0796583850931677,0.0403382598372361,BP,mono-sp-vs-hc
GO:0031023,microtubule organizing center organization,107,-0.33901197283607,-1.30455122625517,0.0392156862745098,0.0796821542876062,0.0403502963345899,BP,mono-sp-vs-hc
GO:0009260,ribonucleotide biosynthetic process,178,0.302820771767885,1.27217866877241,0.0401459854014599,0.0814196670220618,0.0412301565033719,BP,mono-sp-vs-hc
GO:1903530,regulation of secretion by cell,460,0.267084166379565,1.22245259567964,0.0405405405405405,0.0820661783278606,0.0415575437710214,BP,mono-sp-vs-hc
GO:0001890,placenta development,118,0.337624537338389,1.32156231175079,0.040650406504065,0.0821350564251911,0.0415924229941435,BP,mono-sp-vs-hc
GO:0042278,purine nucleoside metabolic process,287,0.285721803314834,1.25543758800608,0.041044776119403,0.0827774535145502,0.0419177268611368,BP,mono-sp-vs-hc
GO:1904589,regulation of protein import,154,0.318480049937009,1.30002589525406,0.0416666666666667,0.0838754646840149,0.0424737494293354,BP,mono-sp-vs-hc
GO:0008544,epidermis development,179,0.314427751742162,1.31131900921275,0.0418250950570342,0.0840381780088461,0.0425561459324574,BP,mono-sp-vs-hc
GO:0007420,brain development,495,0.260280588786039,1.19609264362998,0.0425531914893617,0.0853427895981087,0.0432167890174609,BP,mono-sp-vs-hc
GO:0002285,lymphocyte activation involved in immune response,122,0.336800899304807,1.34016506895626,0.0426356589147287,0.0853501268108155,0.0432205045132282,BP,mono-sp-vs-hc
GO:0022900,electron transport chain,122,0.339691928509179,1.33218242691833,0.0428015564202335,0.085524143179175,0.043308624771687,BP,mono-sp-vs-hc
GO:1901991,negative regulation of mitotic cell cycle phase transition,163,-0.313284753331514,-1.30400846886365,0.043859649122807,0.0874769797421731,0.0442975229097266,BP,mono-sp-vs-hc
GO:1901988,negative regulation of cell cycle phase transition,169,-0.307567096832546,-1.28130041217816,0.0440528634361234,0.0877008292303706,0.0444108781931507,BP,mono-sp-vs-hc
GO:0007268,synaptic transmission,440,0.269795751680367,1.21961673049158,0.0444444444444444,0.0879951249238269,0.0445599067748592,BP,mono-sp-vs-hc
GO:0099536,synaptic signaling,440,0.269795751680367,1.21961673049158,0.0444444444444444,0.0879951249238269,0.0445599067748592,BP,mono-sp-vs-hc
GO:0099537,trans-synaptic signaling,440,0.269795751680367,1.21961673049158,0.0444444444444444,0.0879951249238269,0.0445599067748592,BP,mono-sp-vs-hc
GO:0046390,ribose phosphate biosynthetic process,180,0.299090956739702,1.25354222153312,0.0446096654275093,0.0881610723685996,0.0446439410060168,BP,mono-sp-vs-hc
GO:0045333,cellular respiration,181,0.312759892540864,1.28184486559303,0.0448979591836735,0.0885691981710717,0.0448506120883786,BP,mono-sp-vs-hc
GO:0009108,coenzyme biosynthetic process,117,-0.320144278657284,-1.26263475841711,0.0454545454545455,0.089504132231405,0.0453240539364941,BP,mono-sp-vs-hc
GO:0044033,multi-organism metabolic process,207,-0.30373405971727,-1.29370235125922,0.045643153526971,0.0897124052081843,0.0454295214204831,BP,mono-sp-vs-hc
GO:0051606,detection of stimulus,231,-0.288242609163179,-1.2317962857305,0.0460251046025105,0.0902992541386211,0.0457266962202669,BP,mono-sp-vs-hc
GO:0009123,nucleoside monophosphate metabolic process,236,0.299637402699435,1.26996817726266,0.0466926070038911,0.0909498082467878,0.0460561307251557,BP,mono-sp-vs-hc
GO:0034248,regulation of cellular amide metabolic process,315,0.275553401414681,1.22484398607687,0.0466926070038911,0.0909498082467878,0.0460561307251557,BP,mono-sp-vs-hc
GO:0042176,regulation of protein catabolic process,356,0.263487274493987,1.18088441839185,0.0466926070038911,0.0909498082467878,0.0460561307251557,BP,mono-sp-vs-hc
GO:0043623,cellular protein complex assembly,455,0.263541355076767,1.20717721264109,0.0466926070038911,0.0909498082467878,0.0460561307251557,BP,mono-sp-vs-hc
GO:0002366,leukocyte activation involved in immune response,175,0.305622013748113,1.27343492954719,0.046875,0.091141157989228,0.0461530284418407,BP,mono-sp-vs-hc
GO:0001819,positive regulation of cytokine production,340,0.270261570669755,1.19662291873465,0.047244094488189,0.0916941833883668,0.046433075322291,BP,mono-sp-vs-hc
GO:0031334,positive regulation of protein complex assembly,175,0.299734306087329,1.25685551788639,0.0476190476190476,0.0922565806286736,0.0467178680152976,BP,mono-sp-vs-hc
GO:1901565,organonitrogen compound catabolic process,282,0.280991362975779,1.22499849115507,0.0479704797047971,0.0927714812862414,0.0469786088838332,BP,mono-sp-vs-hc
GO:0051438,regulation of ubiquitin-protein transferase activity,129,-0.319496123827677,-1.27276424421631,0.048582995951417,0.0937885643767997,0.0474936502311441,BP,mono-sp-vs-hc
GO:0010564,regulation of cell cycle process,459,-0.251816459318767,-1.17594802190771,0.0491803278688525,0.0947727670497637,0.0479920412430645,BP,mono-sp-vs-hc
GO:0071248,cellular response to metal ion,108,0.33074378049888,1.30506930175996,0.0501930501930502,0.0965525281688692,0.0488932955979792,BP,mono-sp-vs-hc
GO:0030336,negative regulation of cell migration,145,0.32075896217095,1.30255952031385,0.0503875968992248,0.0965836591891336,0.0489090600549532,BP,mono-sp-vs-hc
GO:0048017,inositol lipid-mediated signaling,160,0.298040917325847,1.22212255419178,0.0503875968992248,0.0965836591891336,0.0489090600549532,BP,mono-sp-vs-hc
GO:1903321,negative regulation of protein modification by small protein conjugation or removal,151,-0.307424023227727,-1.28393912764055,0.0505836575875486,0.0967881646065639,0.0490126196821887,BP,mono-sp-vs-hc
GO:0030111,regulation of Wnt signaling pathway,245,0.283972944449066,1.23051126312142,0.0514705882352941,0.0983115468409586,0.0497840461720751,BP,mono-sp-vs-hc
hsa04723,Retrograde endocannabinoid signaling,62,0.515709497831397,1.84639286416885,0.0034965034965035,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04810,Regulation of actin cytoskeleton,166,0.471155313958803,1.92763209228242,0.00350877192982456,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05202,Transcriptional misregulation in cancer,147,0.425283916690557,1.71683322722645,0.00354609929078014,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05322,Systemic lupus erythematosus,107,0.482770397854644,1.90092661284541,0.00354609929078014,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05131,Shigellosis,62,0.584370901239763,2.04664646443127,0.00355871886120996,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04920,Adipocytokine signaling pathway,63,0.480883166790808,1.71522385093928,0.003584229390681,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04015,Rap1 signaling pathway,163,0.431820868727003,1.76357015599597,0.0036101083032491,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04014,Ras signaling pathway,166,0.382695415899006,1.5672283170872,0.0036231884057971,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04722,Neurotrophin signaling pathway,105,0.448647454102912,1.74151442572951,0.0036231884057971,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05100,Bacterial invasion of epithelial cells,70,0.479792738371929,1.74927453925382,0.0036231884057971,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04668,TNF signaling pathway,102,0.447855289958498,1.73222312177822,0.00364963503649635,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04670,Leukocyte transendothelial migration,93,0.462668712169865,1.7599083086438,0.00364963503649635,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05206,MicroRNAs in cancer,132,0.395973316103442,1.58482069124843,0.00366300366300366,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04145,Phagosome,135,0.450592193874336,1.82191382084584,0.00367647058823529,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04510,Focal adhesion,156,0.428620908354093,1.76132948852832,0.003690036900369,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05205,Proteoglycans in cancer,165,0.36226020091925,1.50098095159865,0.0037037037037037,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04020,Calcium signaling pathway,124,0.387378539016927,1.54342320604674,0.00371747211895911,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05016,Huntington's disease,166,0.433959596125638,1.77717996382732,0.00371747211895911,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04917,Prolactin signaling pathway,62,0.486171585232272,1.72249676972853,0.00373134328358209,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04932,Non-alcoholic fatty liver disease (NAFLD),138,0.396621812124448,1.61893419993097,0.00373134328358209,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05416,Viral myocarditis,54,0.613596077859432,2.13455062306853,0.00373134328358209,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05152,Tuberculosis,152,0.429532836127132,1.78983350968521,0.00374531835205993,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05169,Epstein-Barr virus infection,194,0.386115043120853,1.6304597792219,0.00374531835205993,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04062,Chemokine signaling pathway,156,0.465492331847046,1.86525162147654,0.0037593984962406,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05010,Alzheimer's disease,147,0.412594996889728,1.68190155181911,0.00377358490566038,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05034,Alcoholism,132,0.538368835863896,2.13036449953497,0.00380228136882129,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04010,MAPK signaling pathway,201,0.414694553655721,1.74304538337821,0.00381679389312977,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04725,Cholinergic synapse,81,0.462752795687735,1.73758235175509,0.00381679389312977,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04726,Serotonergic synapse,72,0.483814344317011,1.75377352060873,0.00381679389312977,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04024,cAMP signaling pathway,140,0.442933497594225,1.77331414654475,0.00383141762452107,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04380,Osteoclast differentiation,126,0.444318862018209,1.75987594046271,0.00383141762452107,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04666,Fc gamma R-mediated phagocytosis,84,0.47025473922131,1.73356222178367,0.00386100386100386,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05130,Pathogenic Escherichia coli infection,46,0.505527531919243,1.69193165572805,0.00386100386100386,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa00190,Oxidative phosphorylation,110,0.441482267194533,1.68929550759365,0.00387596899224806,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04611,Platelet activation,103,0.444895133443961,1.68668767152767,0.00387596899224806,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04728,Dopaminergic synapse,94,0.515140944562054,1.94065381900224,0.00387596899224806,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04972,Pancreatic secretion,58,0.519092387022961,1.80827417702919,0.00387596899224806,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05203,Viral carcinogenesis,188,0.408027210300762,1.71343286286852,0.00387596899224806,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04933,AGE-RAGE signaling pathway in diabetic complications,85,0.392293866958866,1.48659029508592,0.00389105058365759,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04210,Apoptosis,131,0.38766356392212,1.53313499234428,0.00390625,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04720,Long-term potentiation,52,0.568349798672051,1.956018642771,0.00393700787401575,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04022,cGMP-PKG signaling pathway,125,0.409851917786999,1.63625046983838,0.00396825396825397,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05012,Parkinson's disease,112,0.44909969681689,1.73392194102923,0.00396825396825397,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05145,Toxoplasmosis,108,0.433289803678391,1.68023699285226,0.00396825396825397,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa03008,Ribosome biogenesis in eukaryotes,70,-0.605716649284881,-2.22454904377532,0.00398406374501992,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04918,Thyroid hormone synthesis,59,0.493601219028027,1.72435255697171,0.00398406374501992,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04970,Salivary secretion,58,0.487581891618265,1.72684746884566,0.00398406374501992,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04514,Cell adhesion molecules (CAMs),109,0.447272065028161,1.75100190265944,0.00401606425702811,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04713,Circadian entrainment,65,0.512924978887196,1.81342828768952,0.00401606425702811,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05140,Leishmaniasis,68,0.476474398357659,1.75480879406139,0.00401606425702811,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05132,Salmonella infection,74,0.412661150150003,1.51789627595281,0.00404858299595142,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa03030,DNA replication,36,-0.536936465864109,-1.72187882765483,0.00409836065573771,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa05133,Pertussis,63,0.493354390929346,1.79142626692371,0.00409836065573771,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa04142,Lysosome,119,0.405668231043165,1.59283540957719,0.00416666666666667,0.0216820987654321,0.0121832358674464,KG,mono-sp-vs-hc
hsa03420,Nucleotide excision repair,45,-0.526135144722854,-1.78160553569152,0.00429184549356223,0.0219274287943816,0.012321087541327,KG,mono-sp-vs-hc
hsa03013,RNA transport,151,-0.412496783890112,-1.66257672777947,0.0045045045045045,0.0226029601029601,0.0127006705954074,KG,mono-sp-vs-hc
hsa04151,PI3K-Akt signaling pathway,245,0.32338374242262,1.40082408941584,0.00719424460431655,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa04610,Complement and coagulation cascades,58,0.461797830496135,1.61924764266378,0.00743494423791822,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa04261,Adrenergic signaling in cardiomyocytes,112,0.384059146531919,1.53111705941975,0.00757575757575758,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa04068,FoxO signaling pathway,123,0.362047974740093,1.43314680807588,0.00763358778625954,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa04662,B cell receptor signaling pathway,69,0.444070323874202,1.60985881883485,0.00769230769230769,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa04915,Estrogen signaling pathway,84,0.40519449746213,1.52421708963331,0.00790513833992095,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa04911,Insulin secretion,55,0.482498642265916,1.6737771681081,0.00796812749003984,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa04630,Jak-STAT signaling pathway,116,0.387342684598536,1.54670021307718,0.00803212851405622,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa04660,T cell receptor signaling pathway,95,0.39118050232453,1.48354850670468,0.00803212851405622,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa05031,Amphetamine addiction,45,0.494196186472928,1.65046686156866,0.00803212851405622,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa04146,Peroxisome,75,-0.419691650259149,-1.54956045343336,0.00819672131147541,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa05150,Staphylococcus aureus infection,47,0.427636701156647,1.44416187475665,0.00823045267489712,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa05412,Arrhythmogenic right ventricular cardiomyopathy (ARVC),56,0.504453330259588,1.75716039467085,0.00823045267489712,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa03430,Mismatch repair,23,-0.629529915045521,-1.85032228797711,0.00833333333333333,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa05032,Morphine addiction,57,0.477361538443576,1.6535851698638,0.00833333333333333,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa04724,Glutamatergic synapse,79,0.449351611333386,1.63527574858198,0.00836820083682008,0.0326592282659228,0.0183513176246054,KG,mono-sp-vs-hc
hsa04520,Adherens junction,65,0.437021043507657,1.57476642462792,0.00888888888888889,0.0342161339421613,0.0192261475606825,KG,mono-sp-vs-hc
hsa04064,NF-kappa B signaling pathway,83,0.413924738350867,1.5155966962721,0.0109090909090909,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa05030,Cocaine addiction,32,0.534400443472015,1.68873930715389,0.0111524163568773,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa04540,Gap junction,64,0.471932233644861,1.69574353346291,0.0112359550561798,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa05146,Amoebiasis,75,0.402956347767094,1.48241947923439,0.0113207547169811,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa04922,Glucagon signaling pathway,81,0.403661173456664,1.48570093153704,0.0113636363636364,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa05215,Prostate cancer,79,0.423055348567186,1.55745789422984,0.0114068441064639,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa04971,Gastric acid secretion,57,0.425548864778762,1.50043857233307,0.0114503816793893,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa00280,Valine, leucine and isoleucine degradation,43,-0.497595739850004,-1.60335948804494,0.01171875,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa04390,Hippo signaling pathway,124,0.378893908954594,1.51686347823469,0.01171875,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa04260,Cardiac muscle contraction,52,0.492605925136583,1.67077360390535,0.0118577075098814,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa04912,GnRH signaling pathway,73,0.436878541857114,1.57831600397097,0.0118577075098814,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa04924,Renin secretion,42,0.470900460963303,1.58138679047843,0.0119047619047619,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa04730,Long-term depression,48,0.502091093614523,1.66374789749137,0.0119521912350598,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa05144,Malaria,37,0.503494353818181,1.63907776612504,0.012,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa05414,Dilated cardiomyopathy,64,0.432437679812751,1.52734284393307,0.012,0.0383181818181818,0.0215311004784689,KG,mono-sp-vs-hc
hsa03450,Non-homologous end-joining,12,-0.698162467982164,-1.74174118893589,0.0127659574468085,0.0398581560283688,0.0223964165733483,KG,mono-sp-vs-hc
hsa04612,Antigen processing and presentation,64,0.398817895949651,1.454401667658,0.0127659574468085,0.0398581560283688,0.0223964165733483,KG,mono-sp-vs-hc
hsa04910,Insulin signaling pathway,119,0.351655167400454,1.40904491982685,0.0138888888888889,0.0428876678876679,0.0240987083092346,KG,mono-sp-vs-hc
hsa05200,Pathways in cancer,318,0.289528819819132,1.26450896180707,0.0142857142857143,0.0433391170233275,0.024352378923016,KG,mono-sp-vs-hc
hsa05164,Influenza A,148,0.362523127330442,1.46324912671444,0.0145985401459854,0.0433391170233275,0.024352378923016,KG,mono-sp-vs-hc
hsa05160,Hepatitis C,103,0.398192901004095,1.52539169007165,0.0146520146520147,0.0433391170233275,0.024352378923016,KG,mono-sp-vs-hc
hsa05221,Acute myeloid leukemia,56,0.427298542316892,1.47843722585391,0.0146520146520147,0.0433391170233275,0.024352378923016,KG,mono-sp-vs-hc
hsa05168,Herpes simplex infection,165,0.349080014284135,1.43436849703043,0.0148148148148148,0.0433641975308642,0.0243664717348928,KG,mono-sp-vs-hc
hsa00480,Glutathione metabolism,44,0.500375788181637,1.68789489936409,0.0150375939849624,0.0435625145337571,0.0244779066494233,KG,mono-sp-vs-hc
hsa04964,Proximal tubule bicarbonate reclamation,16,0.61568033640014,1.59486383642884,0.0155038759689922,0.0441771803639508,0.0248232892099368,KG,mono-sp-vs-hc
hsa05166,HTLV-I infection,230,0.309123373713776,1.32606344549681,0.0155642023346304,0.0441771803639508,0.0248232892099368,KG,mono-sp-vs-hc
hsa00600,Sphingolipid metabolism,39,0.460713420673996,1.5339342581247,0.0163265306122449,0.0458775510204082,0.0257787325456498,KG,mono-sp-vs-hc
hsa03410,Base excision repair,33,-0.514700597165304,-1.62800547717812,0.0177777777777778,0.0494609460946095,0.0277922529095015,KG,mono-sp-vs-hc
hsa04978,Mineral absorption,40,0.476639774448153,1.55959560506317,0.0185185185185185,0.0510167029774873,0.028666437335168,KG,mono-sp-vs-hc
hsa05212,Pancreatic cancer,65,0.40987679742232,1.46437860785542,0.0190839694656489,0.0520640332024013,0.0292549353075864,KG,mono-sp-vs-hc
hsa05410,Hypertrophic cardiomyopathy (HCM),61,0.41549244096472,1.45484867729352,0.0198412698412698,0.0536095848595849,0.0301233853865433,KG,mono-sp-vs-hc
hsa04750,Inflammatory mediator regulation of TRP channels,76,0.402883457827755,1.4762115280529,0.0200803212851406,0.0537387645821381,0.0301959718573542,KG,mono-sp-vs-hc
hsa04012,ErbB signaling pathway,76,0.380535289673146,1.39947141155354,0.0222222222222222,0.0587948109917701,0.0330369793922664,KG,mono-sp-vs-hc
hsa04530,Tight junction,102,0.355642526757563,1.386240472047,0.0223880597014925,0.0587948109917701,0.0330369793922664,KG,mono-sp-vs-hc
hsa04512,ECM-receptor interaction,51,0.429868014071842,1.44673760050191,0.0228136882129278,0.0588728263146868,0.0330808164345496,KG,mono-sp-vs-hc
hsa04060,Cytokine-cytokine receptor interaction,186,0.312058024516318,1.28816133070807,0.0229007633587786,0.0588728263146868,0.0330808164345496,KG,mono-sp-vs-hc
hsa04141,Protein processing in endoplasmic reticulum,158,0.335958573111048,1.37734014579854,0.0231660231660232,0.0588728263146868,0.0330808164345496,KG,mono-sp-vs-hc
hsa04744,Phototransduction,17,0.573162239024822,1.55848330531609,0.0232558139534884,0.0588728263146868,0.0330808164345496,KG,mono-sp-vs-hc
hsa05120,Epithelial cell signaling in Helicobacter pylori infection,60,0.409728080858867,1.44979990664959,0.0251798561151079,0.0631744604316547,0.0354979174555093,KG,mono-sp-vs-hc
hsa05110,Vibrio cholerae infection,44,0.474216893285409,1.56634340102552,0.0264150943396226,0.0649689523054565,0.0365062477835492,KG,mono-sp-vs-hc
hsa05142,Chagas disease (American trypanosomiasis),94,0.352560218782797,1.34962483561752,0.0264150943396226,0.0649689523054565,0.0365062477835492,KG,mono-sp-vs-hc
hsa04925,Aldosterone synthesis and secretion,59,0.424622610915003,1.49587405061372,0.026615969581749,0.0649689523054565,0.0365062477835492,KG,mono-sp-vs-hc
hsa04270,Vascular smooth muscle contraction,83,0.372963903698711,1.37979717021237,0.0268199233716475,0.0649689523054565,0.0365062477835492,KG,mono-sp-vs-hc
hsa01200,Carbon metabolism,95,-0.345148762759632,-1.31907946655616,0.0283400809716599,0.0680646389148413,0.0382457233085829,KG,mono-sp-vs-hc
hsa04120,Ubiquitin mediated proteolysis,130,0.330041951644618,1.31768830636489,0.0306513409961686,0.072991752711215,0.0410142832241328,KG,mono-sp-vs-hc
hsa00071,Fatty acid degradation,33,-0.474553150579551,-1.46329194994966,0.0321285140562249,0.0755376344086022,0.0424448217317487,KG,mono-sp-vs-hc
hsa04071,Sphingolipid signaling pathway,112,0.359877841534979,1.36460484415269,0.032258064516129,0.0755376344086022,0.0424448217317487,KG,mono-sp-vs-hc
hsa04961,Endocrine and other factor-regulated calcium reabsorption,41,0.445555662148513,1.42950085286868,0.0342205323193916,0.0794708229896616,0.044654892108819,KG,mono-sp-vs-hc
hsa04650,Natural killer cell mediated cytotoxicity,98,0.339891518990968,1.29927349097957,0.03515625,0.0809331797235023,0.0454765947125879,KG,mono-sp-vs-hc
hsa00512,Mucin type O-Glycan biosynthesis,25,0.501113021988975,1.46907720243457,0.0354330708661417,0.0809331797235023,0.0454765947125879,KG,mono-sp-vs-hc
hsa00970,Aminoacyl-tRNA biosynthesis,43,-0.443951726118662,-1.45570329096394,0.0357142857142857,0.0809331797235023,0.0454765947125879,KG,mono-sp-vs-hc
hsa04919,Thyroid hormone signaling pathway,108,0.336886389763137,1.32020897670635,0.0384615384615385,0.0864615384615385,0.048582995951417,KG,mono-sp-vs-hc
